About

Dr. Keyur H. Parikh

M.D(USA), FCSI (India), FACC (USA), FSCAI (USA)

• Affiliation

Chairman,

Marengo CIMS Hospital (2021- Till date)

• Contact Details

• Office:

Marengo CIMS Hospital, Near Shukan Mall,

Off. Science City Road, Sola Ahmedabad-380060, Gujarat, India

• Residence:

381-A, 17^th Lane, SatyagrahChhavani, Jodhpur Tekra,

Off Satellite Road, Ahmedabad-380015,

Gujarat, India

• e-mail: keyur.parikh@cims.org,  keyurparikh@gmail.com
• Website:  www.cims.org
• Contact No:

Mobile: +919825026999

Tel : +917926860456

: +18622514377 (USA)

Fax : +917926860456

:+18622514376 (USA)

• Date of Birth: 18^th June, 1958
• Marital Status: Married

• IN BRIEF…

SOCIAL CV

Dr. Keyur Parikh is a practicing interventional cardiologist by profession having over more than 35 years of experience.

Born in Tanzania (East Africa) in 1958, followed by careers in India and USA.

Dr. Parikh completed MBBS with 3 gold medals from Smt.

N.H.L. Municipal Medical College, Ahmedabad, India. He completed Internship in Internal Medicine at Case Western University, Cleveland, USA; residency in Internal Medicine at University of Southern California Medical Center, Los Angeles, USA and Cardiovascular Fellowship including Invasive and Noninvasive Cardiology at Kaiser Permanente Medical Center (UCLA/ USC), Los Angeles, USA.

Dr. Parikh started practicing as a Clinical Cardiologist and Cardiovascular Interventionist from 1987 onwards. He was the Chief of Medicine (1991-1993) at St. Rose Hospital, Hayward, California and Chief of Cardiology/Cardiac Catheterization Laboratory (1990-1991) at St. Rose Hospital, Hayward, California.

For good reasons he migrated back to India in 1994 and was associated with various hospitals. Between 2001 and 2005, Dr. Parikh was the Director at Cardiac Catheterization Laboratory, Sterling Hospital, Ahmedabad. He is founder and holds a chairmanship of CIMS Hospital Pvt. Ltd, a 350 bedded multi- super specialty state-of-the-art “Green Eco-friendly” Hospital since it’s inception in 2010 till now. CIMS Hospital has created a history by performing First Heart Transplant Surgery in Gujarat, and first Transcatheter Aortic Valve Implantation (TAVI).

Dr. Parikh is a Fellow of Cardiac Society of India (FCSI), Fellow of American College of Cardiology (FACC), Fellow of European Society of Cardiology (FESC), Fellow of Society for Cardiac Angiography and Interventions (FSCAI), Fellow of International Academy of Cardiovascular Sciences (FIACS), Member of American Medical Association (AMA), USA, Member of working group on Pathogenosis of Atherosclerosis of the ESC and Academy of TCT, USA.

CIMS Hospital merged with Marengo Asia Healthcare Pvt.Ltd, in October 2021, where Dr.Keyur Parikh still continues stay on the Board and as Chairman of the Hospital.

Dr. Parikh is a recipient of several awards, the most prestigious one has been the 2004 International Service Award by the American College of Cardiology in recognition of the contribution to the ACC and to the international cardiovascular community, as well as listed for many years in “Who’s Who”/ Marquis.

He also received the “LIFETIME ACHIEVEMENT AWARD IN CARDIOVASCULAR SCIENCE,

MEDICINE AND SURGERY” by the International Academy of Cardiovascular Sciences, Winnipeg, Canada in year 2011. He is considered amongst the “100 Ratno (jewels) of Gujarat” (2011).

At home front, Dr. Parikh received the “IMA DR.K.SHARAN CARDIOLOGY EXCELLENCE AWARD” by Indian Medical Association (HQS) for the year 2010 and again in year 2014.

Dr. Parikh received “GLORY OF GUJARAT AWARD” organized by Indian Council of Social Welfare- ICSW Gujarat State, for the services and dedication given to the medical Industry by Honorable Governor of Gujarat Smt. Kamla Beniwal (2013).

He also received the Global Summit 2014 “Leadership Award” organized by AAPI-American Association of Physician of Indian Origin, the Award was presented by Chief Minister of Gujarat Shri. Narendra Modi (2014).

Awarded by “Headlines Today”- A group of India Today for “Healthcare Excellence Award for Best Angioplasty Specialist” in India (2013).

Dr. Parikh received “Dr. Nandagudi Suryanarayana Rao Award” organized by NAMS (National Academy of Medical Sciences) for his contribution to the research in the topic name: Unique Aspects of Coronary Artery Diseases in India Women (2016).

As an interventional cardiologist, Dr. Parikh has proficiently conducted over 25000 PTCA/PCI; over 500 peripheral interventions and 15000 complex multi-vessel graft procedures; coronary directional atherectomies; Intravascular Ultrasound (IVUS),Optical Coherence Tomography and Electrophysiology studies; conducted endomyocardial biopsies and used innovative Devices. As a clinical trial Investigator, he has participated in more than 88 global drug and device clinical studies. He is a pioneer in use of Intravascular Lithotripsy (Shockwave) Therapy in India.

Dr. Parikh has contributed tremendously to the research front and authored numerous (more than 150) International and National research/review articles in various scientifically acclaimed journals besides serving as a guest writer. He is an International Advisor to American College of Cardiology and the reviewer of International Journal of Cardiology and Elsevier publication.

Since last 13 years, has been organizing annual physician conference, which clubs renowned cardiologist from world over with attendance exceeding 2000 delegates in recent years. On invitation have delivered lectures at various international/national meets.

As a Philanthropic virtue, Dr. Parikh holds Trusteeship for Reeta Keyur Parikh Charitable Trust and a Trustee for CIMS Foundation to support education and research.

His biggest contribution in India came in 2020-2021 during the Covid crises.

When called upon in April 2020 by the Government of Gujarat, India for the care of Covid patients, Dr. Parikh offered hundreds of beds in his CIMS Hospital to be allotted for COVID patients despite resistance

from other private hospitals in the city of Ahmedabad. This model of PP Partnership led to one of the most successful administrative and medical projects ever in state of Gujarat and India for the care of many thousands of COVID patients at his hospital

• POSITIONS AND HONORS

Gujarat Medical Council Registration Number: G – 11958 State of California (USA) No: A040990

As Cardiologist (India) and Management

1. Chairman, Marengo CIMS Hospital (2021- Till date)

2. Chairman, CIMS Hospital (2010- 2021)

3. Chairman, Cardiovascular Consultants Pvt. Ltd. (2001-2013)

4. Director, V.S. General Hospital, Ahmedabad (2006-2008)

5. SAL Hospital, Ahmedabad (2004 – 2008)

6. Director, Sterling Hospital (2001-2004)

7. GRMI (Rajasthan Hospital) (1995-2001)

As Cardiologist (USA)

1. Washington Township Hospital, Fremont (1987-1995)

2. St. Rose Hospital, Hayward (1987-1995)

3. San Jose Medical Center, San Jose (1987-1995)

As Clinical Faculty (USA)

Clinical Instructor – Stanford University Medical Center, Palo Alto (1988-1995)

Other Appointments

• Trustee for Reeta Keyur Parikh Charitable Trust (Indian Registration No. E/16549 Ahmedabad) an organization serving philanthropy to widows, orphan children, disadvantaged women etc.
• Trustee CIMS Foundation (Registration No.: E/19602/Ahmedabad) -supporting education, research.
• Member of Advisory Committee of IIPH – Gandhinagar for Master in Hospital Administration Program

• PROFESSIONAL FELLOWSHIP

FACC – Fellow of American College of Cardiology, USA

FCSI-Fellow of Cardiac Society of India

• EDUCATION

Cardiovascular fellowship: Including Invasive and Noninvasive cardiology July 1985 to June 1987 at Kaiser Permanente Medical Center (UCLA/USC), Los Angeles, USA

2 months of Echocardiography between 1983 -1985 at University of Southern California, Los Angeles. Few months of clinical, Diagnostic & Inv. Electrophysiology At Kaiser Permanente, Panorama City and Good Samaritan Hospital, Los Angeles, California with Dr. David Cannom.

Residency in Internal Medicine: PGY – 2 & PGY – 3 (July 1983 to June 1985) at University of Southern California Medical Center, Los Angeles, USA

Internship in Internal Medicine (July 1982 to June 1983) Case Western University Affiliated Program

– 4, St. Lukes Hospital, Cleveland, USA

Rotating Housemanship:

V.S. Hospital and affiliated Hospitals in Ahmedabad, Gujarat, India (1980 – 1981)

Medical College:

Smt. N. H. L. Municipal Medical College, Ahmedabad, (India) (1980)

Pre-Medical:

Gujarat college of Ahmedabad (India) with Biology, Physics & Chemistry as majors. Grade “A+” in 1975-76

College:

Pre – Science class at St. Xavier’s College Ahmedabad (India) with Biology, Physics & Chemistry as Major. Grade “A+” in 1974 -75

Schooling:

St Xavier High School Ahmedabad (India) up to Class 11th Science & Mathematics (Major) received Grade “A+” (finished school certificate in the top 1%) – Stood among the top ten in the city.

Primary School:

Daresalaam, Tanzania

• ACADEMIC ACHIEVEMENTS

Alumnus of the Harvard Business School, Owner/President Management (OPM Program-48) in 2014-2016

Samson Global Leadership Academy- Cleveland Clinic

Alumnus Samson Global Leadership Academy for Healthcare Executive, Cleveland Clinic Foundation USA in year 2013

Medical Graduation

Bachelor of Medicine & Bachelor of Surgery (M.B.B.S) India (1980)

I to III M.B.B.S. – Grade “A+” from 1976-80.

Stood among the top three in class in all the three years.

III M.B.B.S.

Distinction and “Gold Medal” in Obstetrics and Gynecology (1979-1980) and first in the College with highest marks in the theory paper of Medicine

II M.B.B.S.

First in Pathology in the University (1978-79) and awarded “Dr. M. S. Kanvinde Gold Medal”

I M.B.B.S.

Distinction and all time University highest Marks (1977-78) and awarded Dr. Mehta Gold Medal in Anatomy

Pre-Medical Course

First in the Class with all-time highest marks in all subjects in all colleges

• AWARDS

AMERICAN COLLEGE OF CARDIOLOGY – 2004 International Service Award

Awarded for:

o Commitment in cardiology in medically developing or underdeveloped countries

o Having provided specific service to enhance cardiovascular care and / or education in medically developing or underdeveloped countries

o For continuous dedication to international causes

o For being a role model for others to follow

The award is in recognition of the contribution to the ACC and to the international cardiovascular community

• Awarded by (Dr. Nandagudi Suryanarayana Rao Award), organized by NAMS (National Academy of Medical Sciences) for his contribution to the research in the topic name: Unique Aspects of Coronary Artery Diseases in India Women November 2016.
• Awarded by (AACOI – American Association of Cardiologists of Indian Origin)
• “Special Award to Dr. Keyur Parikh” for contributions to cardiology, March 2015.
• Awarded by (AAPI-American Association of Physician of Indian Origin) Global Summit 2014 “Leadership Award” the Award was presented by Chief Minister of Gujarat Shri Narendra Modi January 2014.
• Awarded by (Indian Council of Social Welfare-ICSW Gujarat State) “GLORY OF GUJARAT AWARD” for dedication and distinguished role in Cardiologist and Cardiovascular filed as a Devoted Doctor and Social Activist by Honorable Governor of Gujarat Smt. Kamla Beniwal December 2013.
• Awarded by (Worldwide Achievers Private Limited “India’s leading Market Research Company”) “Healthcare Excellence Awards 2013” for best Innovative Hospital in Gujarat December 2013.
• Awarded by (Worldwide Achievers Private Limited “India’s leading Market Research Company”) “Headlines Today”– A group of India Today for “Best Angioplasty Specialist” in India December 2013.
• Awarded by Divya Bhaskaras one of the contemporary achievers in “The 100 Power list, 2010”- ‘100 Ratno (Jewels) of Gujarat’-Biennial list released this Swarnim year-celebrates not only the eminence of Gujarat in its 50 years of glory but also salutes all those achievers and entrepreneurs who have shaped the success of the state. April 2011 and again in July 2013.
• Included by Marquis Who’s Who Publications Board in “Who’s who in Medicine and Healthcare”-Fifth edition, 2004-05; 2009-2010; 2010-2011 (Inclusion limited to those individuals who have demonstrated outstanding achievement in their own fields of endeavor and who have contributed significantly to the betterment of contemporary society.)
• Awarded by Indian Medical Association (HQS)
• Awarded by the International Academy of Cardiovascular Sciences, Winnipeg, Canada – “LIFETIME ACHIEVEMENT AWARD IN CARDIOVASCULAR SCIENCE, MEDICINE AND SURGERY” February 2011
• “IMA DR. K. SHARAN CARDIOLOGY EXCELLENCE AWARD” for the year 2010 and again in year 2014.
• Ahmedabad Medical Association (Branch of Indian Medical Association)
• Awarded the “B. N. Mehta Oration-2002”, a yearly oration awarded to distinguished doctors once a year, in Ahmedabad, India. Subject: “Evidence Based Medicine”
• Order of William Harvey Member of the “Order of William Harvey” (ACC, November 1991)

• AUTHORSHIP:

2^nd Edition: Author of the book: “Hriday ni Vat Dil Thi”: Year of Publication 2013, a 200 pages Book on heart diseases for lay person in Gujarati (Indian Language).

Author of the book: “Hriday ki Baat Dil Se”: Year of Publication 2007, a 146 pages Book on heart diseases for lay person in Hindi (Indian Language).

Author of the book: “Heart to Heart”: Year of Publication 2007, a 146 pages Book on heart diseases for lay person in English.

Author of the book: “Hriday ni Vat Dil Thi”: Year of Publication 2006, a 146 pages Book on heart diseases for lay person in Gujarati (Indian Language).

• EDITOR:

Healthy Heart-A monthly magazine for doctors on Heart Disease (circulation: 25,000)

Maru Hriday( My Heart-In Gujarati)-A monthly magazine for cardiac patients( circulation 200,000)

Dil Se (From The Heart-In Hindi)-A monthly magazine for cardiac patients in Hindi(Circulation 20,000)

Cims Care and Cure-A monthly magazine in healthcare promoted by CIMS hospital(circulation 200,000)

• LEAD GUEST EDITOR:

Lead Guest Editor: “Journal of Diabetes Research” – Special issue “Cardiac Complications of Diabetes: Recent Advances in Pathogenesis and Treatment” Hindawi Publishing Corporation

• LEADERSHIP

Chairman, CIMS Hospital Ahmedabad, India, a 350 bed hospital. (2013-till date)

Director, Cardiovascular Department; Sheth V. S. Hospital and N.H.L. Municipal Medical College, Ahmedabad, India (2006-2008)

Chairman, Cardiovascular Services, SAL Hospital (2004-2007)

Director, SAL Hospital (2004-2007)

Chairman, Care Cardiovascular Consultants Pvt. Ltd. (2001-2013)

Director, Sterling Hospital (2001-2004)

Director, Cardiac Catheterization Laboratory, Sterling Hospital (2001-2004)

Chief of Medicine (1991 – 1993) at St. Rose Hospital, Hayward, California

Chief of Cardiology / Cardiac Catheterization Laboratory (1990 – 1991) at St. Rose Hospital, Hayward, California

• PROFESSIONAL EXPERIENCE

• Cardiac Interventions

• Over 40000 Rt. Lt. cardiac catheterizations including complex coronary angiograms, valvular heart disease, grafts etc

• Over 15,000 PTCA/PCI including complex multi-vessel grafts etc

• Transcatheter Aortic Valve Replacement (TAVR)

• Coronary Directional Atherectomies
• Coronary High Speed Rotational Atherectomies/Ablations
• Coronary Intravascular Ultrasound studies, FFR (Fractional Flow Reserve)
• Electrophysiology studies (SVT and V. Tachycardia, Mapping etc. and Ablations
• Endomyocardial Biopsies
• Permanent Pacemakers (Including Dual Chamber Rate Responsive Pacing etc.), Defibrillators etc
• M-Mode, 2-D Doppler. Stress Echo & Trans esophageal Echocardiography.
• Innovative Devices: Ten successful cases of OVALUM-CiTop, (FIM)
• 33 successful cases of ORBITAL ATHERECTOMY Device for calcific coronary arteries(FIM)
• Ten successful cases of Neovasc Reducer® Coronary Sinus stent (a first in human trial) to evaluate the safety of the Neovasc Reducer™ in the treatment of Ischemic heart Disease (IHD), controlled narrowing of the coronary sinus
• Ten successful cases of Remon Impressure® Device placed in pulmonary artery (a first in human trial-PAPIRUS) to evaluate the safety of the Remon Impressure Device to measure Pulmonary artery pressure in heart failure patients responding to ultrasonic signals

• Peripheral interventions 
• Over 500 cases of Peripheral Interventions. Complex lesion iliac, SFA Tibio- Peroneal A., Renal A., Subclavian A etc.
• Over 100 Percutaneous Intra-Vascular Stenting Procedures including Iliac, Ilio-femoral, Abdominal Aorta Stents, Renal A., Subclavian and Brachiocephalic A etc
• Over 500 cases of Peripheral Diagnostic Angiography with Run-off
• Carotid Stenting / Use of Distal Protection Devices

• CONFERENCES AND SEMINARS CONDUCTED

• JIC 2018 (January 5-7, 2018): Pandit Dindayal Upadhyay Community Hall and CIMS Hospital, Ahmedabad: Organized by Care Institute of Medical Sciences & The Heart Care Clinic
• Website: http://www.jicindia.org/ OR www.cimsre.org
• JIC 2017 (January 6-8, 2017): Tagore Hall and CIMS Hospital, Ahmedabad: Organized by Care Institute of Medical Sciences & The Heart Care Clinic
• Website: http://www.jicindia.org/ OR www.cimsre.org
• JIC 2016 (January 8-10, 2016): Tagore Hall and CIMS Hospital, Ahmedabad: Organized by Care Institute of Medical Sciences & The Heart Care Clinic
• Website: http://www.jicindia.org/ OR www.cimsre.org
• JIC 2015 (January 23-25, 2015): Tagore Hall and CIMS Hospital, Ahmedabad: Organized by Care Institute of Medical Sciences & The Heart Care Clinic
• Website: http://www.jicindia.org/ OR www.cimsre.org
• JIC 2014 (January 10-12, 2014): Tagore Hall and CIMS Hospital, Ahmedabad: Organized by Care Institute of Medical Sciences & The Heart Care Clinic
• Website: http://www.cimscon.com/ OR www.cimsre.org
• CIMSCON 2013 (January 4-6, 2013): Tagore Hall and CIMS Hospital, Ahmedabad: Organized by Care Institute of Medical Sciences & The Heart Care Clinic
• Website: http://www.cimscon.com/
• CIMSCON 2012 (January 6-8, 2012): Tagore Hall and CIMS Hospital, Ahmedabad: Organized by Care Institute of Medical Sciences & The Heart Care Clinic

Website: http://www.cimscon.com/

• CIMS-3C-CON 2011(February 1-6, 2011) –MS University, Baroda and Tagore Hall, Ahmedabad: Organized by Care Institute of Medical Sciences & The Heart Care Clinic, International Academy of Cardiovascular Sciences, International Society for Heart Research, Maharaja Sayajirao University of Baroda

Website: http://www.cimscon.com/

• 3-C Con 2010 (Jan 8 – 10, 2010) – Tagore Hall, Ahmedabad: Organized by The Heart Care Clinic. Website: http://www.cimscon.com/Previous%20Conferences%20PDF/3-C%20Con%202010.pdf
• 3-C Con 2009 (Jan 9 – 11, 2009) – Tagore Hall, Ahmedabad: Organized by The Heart Care Clinic. Website:http://www.indianheart.com/3ccon2010/images/First%20Announcement%20(17-3- 2009)-4.pdf
• 3-C Con 2008 (Jan 11- 13, 2008) – Tagore Hall, Ahmedabad: Organized by The Heart Care Clinic. Website: http://www.indianheart.com/3-C%20Con%202008.pdf
• 3-C Con 2007 (Jan 26 – 28, 2007) – “Recent Updates in Cardiovascular Medicine”, Tagore Hall, Ahmedabad: Organized by The Heart Care Clinic.

Website: http://www.indianheart.com/3-C%20Con%202007.pdf

• 3-C Con 2006-“Novelties and Advances in Cardiovascular Medicine”,Nirma University, Ahmedabad: Organized by The Heart Care Clinic.

Website: http://www.indianheart.com/3-C%20Con%202006.pdf

• “Joint International Conference” (JIC) -2005, 31st Dec 2004 to 2nd Jan 2005.( 800 + delegates conference with over 50 International Faculty)

Website: http://www.indianheart.com/JIC-2005.pdf

• The Conferences was jointly organized by:

1. Care Cardiovascular Consultants
2. International Academy of Cardiovascular Sciences (India Section)
3. International Society for Heart Research (India Section)

• In Association with:

1. American Association of Physicians of Indian Origin (AAPI)
2. American Association of Cardiologists of Indian Origin (AACIO)
3. Gujarat Medical Education and Research Society (GMERS Sola)

• TEACHING SEMINARS CONDUCTED: BEFORE 2005

Year 2002 – 2005

Course Director in the following Major CME programs in Ahmedabad

• Symposium: Emerging Concepts in Cardiology, 24 & 25 Jan. 2004 and 4 & 5 Sep. 2004
• Seminar on Congenital Heart Disease, 25 Jul. 2004 and 11 Dec. 2004
• Symposium: EKG, Arrhythmias & EP Studies, 21 & 22 Feb. 2004 and 9 & 10 Oct. 2004
• Comprehensive CPR & Critical Care Course, 20& 21 Mar. 2004 and 14 & 15 Aug 2004
• Comprehensive Echocardiology Course, 3 & 4 Jan 2004 and 10 & 11 Jul 2004
• Comprehensive Arrhythmia and Interventional Electrophysiology – 11 & 12 January 2003
• Basic and Advanced Course in Cardiopulmonary Resuscitation Feb 8 & 9, 2003
• Symposium and Update in Cardiovascular Disease, March 8 & 9, 2003
• Comprehensive ECG, Arrhythmias & Electro-Physiology Course, April 26 & 27, 2003
• Comprehensive Echocardiography Course, June 27, 28 & 29, 2003
• Updates in Congenital Heart Disease, July 13, 2003
• Updates in Cardiology for Family Physicians , 20 July 2003
• Symposium and Update in Cardiovascular Disease, August 2 & 3, 2003
• Comprehensive ECG, Arrhythmias & Electro-Physiology Course, August 30 & 31, 2003
• Cardio-Pulmonary Resuscitation and Critical Care, September 13 & 14, 2003
• Symposium and Update in Cardiovascular Disease, September 27 & 28, 2003
• Comprehensive ECG, Arrhythmias & Electro-Physiology Course, November 8 & 9, 2003
• Cardio-Pulmonary Resuscitation and Critical Care, November 22 & 23, 2003
• Updates in Congenital Heart Disease, December 13 & 14, 2003
• Symposium and Update in Cardiovascular Disease – 10 & 11 August 2002
• Symposium and Update in Cardiovascular Disease – 14& 15 September 2002
• Advances in Pediatric Cardiology – 17 Nov 2002
• Symposium and Update in Cardiovascular Disease – 21 & 22 December 2002

1995-2004

Organized over 30 conferences in India, Ahmedabad.

1994-2003

Guest Speaker at Multiple Conferences and talks in India

1997

International Proctor to demonstrate the use of Wiktor Stent (Medtronic) in USA

January 1994

• Conducted live/hands-on workshop in Interventional Cardiology at B. Y. L. Nair Hospital, Mumbai with Dr. Leelam Shah
• Conducted live/hands-on workshop in Interventional Cardiology at Ruby Hall Hospital, Pune
• Conducted live/hands- on workshop in Interventional Cardiology at Shri Chitra Hospital, Trivandrum
• Conducted live/hands –on workshop in Interventional Cardiology at PGI, Chandigarh with Dr. Saproo
• Conducted live/hands- on workshop in Interventional Cardiology at Jayadeva Hospital, Bangalore with Dr. Chandrashekar
• Conducted live/hands – on workshop in Interventional Cardiology at C M C Medical Center, Ludhiana with Dr. Jaison

June-July 1993

• Conducted live/hands on workshop in Interventional Cardiology at B. Y. L. Nair Hospital, Mumbai with Dr. Leelam Shah
• Conducted live/hands – on workshop in Interventional Cardiology at S. D. Hospital and Research Center, Jaipur
• Conducted live/hands-on workshop in Interventional Cardiology at Nizam Institute of Medical Science, Hyderabad with Dr. Raju and his group
• Intra Vascular Peripheral Stents were used in India for the First time with possibly the first use of metallic stent percutaneously in Takayasu’s Abdominal Arteritis with Abdominal Aorta stenosis
• Conducted live / hands-on workshops in Interventional Cardiology at Railways Hospital, Chennai with Dr. Abraham Conducted live/hands –on workshop in Interventional Cardiology Sri Jaydeva.

May 1992

Interventional Cardiology-live/hands on course at Post Graduate Institute, Calcutta

Visiting Lectures/Talks in Mumbai, Bangalore, Ahmedabad, and Vadodara on Interventions in Cardiovascular disease

November 1992

Conducted live/hands – on workshop in Interventional Cardiology at Railway Hospital, Chennai with Dr

K.A. Abraham Conducted live/hands-on workshop in Interventional Cardiology at P.G.I, Chennai Conducted live/hands on workshop in Interventional Cardiology at Bombay Hospital, Mumbai with Dr. Pereira Visiting Lectures in Bombay, Bangalore and Chennai

• Institute of Cardiology, Bangalore Conducted live/hands – on workshop in Interventional Cardiology at Breach Candy Hospital, Mumbai with Dr. Pahlajani.
• Visiting Lectures and Demonstrations of Videotaped cases at Mumbai, Jaipur, Hyderabad, Chennai, Bangalore & Calcutta (At B.M. Birla Institute and P.G Institute)

1988-1991

Peripheral Angioplasty in Mumbai, at President Hotel, sponsored by Dr. Navin Nanda

December 1998

Coronary Angioplasty in Ahmedabad in V. S. Hospital

December 1998

Controversies in C.H.F. in Ahmedabad at V. S. Hospital in December 1988

• CONDUCTED WORKSHOPS IN CALIFORNIA (USA)

• Spring/Post-ACC Workshop in Interventional Cardiology and Peripheral work from March 21-24, 1994
• Fall Workshop in Interventional Cardiology and Electrophysiology from September 26 to 30, 1994
• Fall Workshop in Interventional Cardiology and Electrophysiology from November 7-11, 1993
• Summer Workshop in Interventional cardiology and EPS in August 1993
• Spring Workshop in PTCA, DCA and Permanent Pacemakers, Electrophysiology & Radiofrequency ablations etc in March 1993

• INVESTIGATOR: CLINICAL TRIALS

INTERNATIONAL CLINICAL TRIALS

1. Principal Investigator for RUBY registry (For India) (2002). To evaluate Percusurge / Guardwire Distal Protection Device (Presented by Dr. Aman, Switzerland). Presented TCT October 2003, Sponsored by Medtronics Pvt. Ltd. Trial Completed
2. Principal Investigator at Sterling Hospital for Extract-TIMI 25 Multicentre multinational Trial (2003). Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction –Study 25. Presented at ACC 06. Trial Completed
3. To Evaluate the Efficacy and Safety of Fondaparinux versus Enoxaparin in the Acute Treatment of Unstable Angina or Non ST-Segment Elevation Myocardial Infarction Acute Coronary Syndromes. Presented in ESC, Stockholm, Sweden. Trial Completed
4. Principal Investigator for OASIS-6 Trial (2004). To Evaluate the Efficacy and Safety of Fondaparinux Sodium versus Control Therapy and Glucose-Insulin-Potassium Infusion versus Control in Broad Range in Patients with ST -Segment Elevation Acute Myocardial Infarction. Presented at ACC 06. Trial Completed
5. Principal Investigator for TRUST Trial (2004). To Evaluate the Safety and Efficacy of Intravenous Remodulin^® in Patients (in India) with Pulmonary Arterial Hypertension (PAH) in 12-week. Trial completed.
6. Co-Investigator for Paediatric Hypertension Trial (2005). Dose Ranging Study to Evaluate the Safety and Efficacy of Olmesartan medoxomil in Children and Adolescents with Hypertension. Trial completed.
7. Principal Investigator for Hypercholesterol study (NK-104-301) at The Heart Care Clinic/CIMS (2005). Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up Titration) in Patients with Primary Hypercholesterolemia or Combined Dyslipidemia. Trial completed.
8. Principal Investigator for Neovasc Reducer™ Pilot Study, First in human: (2005). To Evaluate the Safety of the Neovasc Reducer™ in the Treatment of Ischemic Heart Disease (IHD), Controlled Narrowing of the Coronary Sinus. Presented at TCT, 2005. Trial Completed
9. Principal Investigator For PAPIRUS Trial: Pilot Study, First in Human: Apollo Hospital (2005). Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (REMON Device). Trial completed
10. Principal Investigator for Export study (2006). Flow Improvement in Patients with Acute Myocardial Infarction Undergoing Either Conventional Stenting or a Strategy of Primary Aspiration Followed by Stenting Using the Export® Aspiration Catheter: a Prospective, Randomized, Controlled Study. Trial completed.
11. Principal Investigator for E-five registry (for India) (2006). To Evaluate the ‘Real World’ Clinical Performance of the Medtronic Endeavor™ ABT-578 Eluting Coronary Stent System. Trial completed.
12. Co- Investigator for RELY study (2006). Randomized Evaluation of Long Term Anticoagulant Therapy Comparing Efficacy and Safety of Two Blinded Doses of Dabigatran etexilate with Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation : Prospective, Multi-Centre, Parallel Group, Non-Inferiority Trial. Trial completed
13. Principal Investigator for Hypercholesterolemia study (NK-104-307) at The Heart Care Clinic/CIMS (2006). Open Label, Long-Term (1year) Extension Study of Pitavastatin 4 mg QD in Patients with Primary Hypercholesterolemia or Combined Dyslipidemia. Trial completed.
14. Principal Investigator for e-SELECT Registry (2007). The e-SELECT Registry: A Multicenter Post Marketing Survelliance. Trial completed.
15. Principal Investigator for Early ACS trial (2007). Early Glycoprotein IIb/IIIa Inhibition in Non-ST- segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients with Non-ST- segment Elevation Acute Coronary Syndrome (EARLY ACS). Trial Completed.
16. Principal Investigator for PLATO trial (2007). A Randomized, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compares with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO – A study of PLATelet inhibition and Patient Outcomes.] Trial completed.
17. Principal Investigator for OASIS- 7 trial (2007). Randomized, Multinational, Double-blind study, Comparing a High Loading Dose Regimen of Clopidogrel versus Standard Dose in Patients with Unstable Angina or Non-ST Segment Elevation Myocardial Infarction Managed with an Early Invasive Strategy. Trial completed.
18. Principal Investigator for New Guidewire (2007). First in Man: A Feasibility Study to Evaluate Safety and Efficacy of New Guidewire for Crossing Total Occlusions in Coronary Arteries. Trial completed.
19. Co-Investigator for Paediatric Hypertension Trial, The Heart Care Clinic/CIMS, Ahmedabad (2007). A Randomized, Double blind, Placebo-Controlled, Multicenter, Parallel Study Assessing the Efficacy, Safety, and Dose Response of Ramipril for the Treatment of Hypertension in Children and Adolescents. Trial completed.
20. Co-Investigator for Aristotle Trial at The Heart Care Clinic/CIMS, Ahmedabad (2007). Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation: Active Controlled Randomized Double Blind Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Subject with Non-valvular Atrial Fibrillation. Trial completed.
21. Co-Investigator for Rocket Trial at The Heart Care Clinic/CIMS, Ahmedabad (2007). Multicenter, Randomized, Double-blind – Dummy, Parallel-group, Non-inferiority Trial Comparing the Efficacy and Safety of Once-daily Oral Rivaroxaban (BAY 59-7939) with Adjusted-dose Oral Warfarin for the Prevention of Stroke and Non-central-nervous-system Systemic Embolism in Subjects with Non- valvular Atrial Fibrillation. Trial completed.
22. Principal Investigator for PROTECT Trial (2007). Patient Related Outcomes with Endeavor versus Cypher Stenting Trial: Prospective, Multicenter, Randomized, Two-arm, Open-label Trial. Trial Completed
23. Principal Investigator for TMC-CAN-05-02 (2007). A Clinical Trial Comparing Cangrelor to Clopidogrel in Subject who Require Percutaneous Coronary Intervention. Trial completed.
24. Principal Investigator for TMC-CAN-05-03 (2008). A Clinical Trial Comparing Treatment with Cangrelor (in combination with usual care) to Usual Care in Subjects who Require Percutaneous Coronary Intervention. Trial completed.
25. Co-Investigator for RELY AF Registry (2008).: Risk Factors, Treatments and Outcomes for Emergency Department Patients with Atrial Fibrillation in Multiple Regions of the World. Trial Completed.
26. Principal Investigator for CL (Ivabradine) at The Heart Care Clinic/CIMS (2008). Evaluation of the Anti-anginal Efficacy. Trial Completed.
27. Principal Investigator for RE-DEEM at The Heart Care Clinic/CIMS (2008). Randomized Dabigatran Etexilate Dose Finding Study in Patients with Acute Coronary Syndromes Post Index Event with Additional Risk Factors for Cardiovascular Complications also Receiving Aspirin and Clopidogrel: Multi-centre, Prospective, Placebo Controlled, Group Dose Escalation Trial. Trial completed.
28. Co-Investigator for Magellan Trial (2008). A Multicenter, Randomized, Parallel-group Efficacy Superiority Study in Hospitalize Medically Ill Patients Comparing Rivaroxaban with Enoxaparin. Trial completed.
29. Co-Investigator for Borealis Trial at The Heart Care Clinic/CIMS Ahmedabad (2008). A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) with Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patient with Atrial Fibrillation. Trial Completed.
30. Principal Investigator for Freedom-PAH at The Heart Care Clinic/CIMS. FREEDOM UT –15C Studies (TDE-PH-302 and TDE-PH-304) Conducted by United Therapeutics. Follow ups Ongoing.
31. Principal Investigator for ORBIT – 1. Pilot Study to Evaluate the Safety & Performance or the Diamondback 360^TM Orbit Atherectomy System in Treating De Novo Calcified Coronary Lesions – Orbit –I. Trial completed.
32. Co-Investigator for AVERROES at The Heart Care Clinic/CIMS. CV 185-048: A Phase 3, Active (Aspirin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate the Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation. Trial Completed.
33. Principal Investigator for Red-HF at The Heart Care Clinic/CIMS. A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia –. Trial Completed.
34. Principal Investigator for TAK-442-202 at The Heart Care Clinic/CIMS. A Phase II, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects with Acute Coronary Syndrome. Trial completed.
35. Principal Investigator for EISAI-202 at The Heart Care Clinic/CIMS. A Randomized, Double-Blind Placebo Controlled Study of the Safety and Tolerability of E5555 and its Effect on Clinical Event and Biomarkers in Patient with Non-ST Segment Elevation Acute Coronary Syndrome. Trial completed.
36. Co-Investigator for E-Resolute at the Heart Care Clinic/CIMS. Evaluation of the Endeavor Resolute Zotarolimus -Eluting Coronary Stent System in a ‘Real World’ Patient Population. Follow-up ongoing.
37. Principal Investigator of RIVAROXABAN at The Heart Care Clinic/CIMS. Randomized, Double Blind, Placebo Controlled, Event Driven, Multi-Center Study To Evaluate The Efficacy And Safety of Rivaroxaban in Subjects With Recent ACS. Trial completed.
38. Principal Investigator of Pfizer PAH at The Heart Care Clinic/CIMS B1321001. A Phase 3, Multi- center, Randomized, Double Blind, Placebo Controlled, Safety and Efficacy Study of Sitaxsentan Sodium in Subjects with Pulmonary Arterial Hypertension. Trial Completed
39. Principal Investigator of Pfizer PAH at The Heart Care Clinic/CIMSB1321002. A Phase 3, Multi Center, Open Label Study To Evaluate The Long Term Safety of Monotherapy Sitaxsentan Sodium And Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension. Trial Completed
40. Principal Investigator of Pfizer PAH at The Heart Care Clinic/CIMSB1321003. A Phase 3, Multi Center, Randomized, Double Blind, Efficacy and Safety Study of Monotherapy Sitaxsentan Sodium versus Combination Therapy with Sitaxsentan Sodium and Sildenafil Citrate in Subjects with Pulmonary Arterial Hypertension who have Completed Study B1321001. Trial Completed
41. Principal Investigator of LPL STABILITY at The Heart Care Clinic/CIMS. A Clinical Outcome Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Event (MACE). Trial Completed.
42. Principal Investigator of OASIS-8 at The Heart Care Clinic/CIMS. A Prospective Study Evaluating the Safety of Two Regimens of Adjustive Intravenous UFH PCI in High Risk Patients with UA/NSTEMI Initially Treated with Subcutaneous Fondaparinux and Referred for Early Coronary Angiography. Trial Completed
43. Co-Investigator of STEM CELL. A Randomized, Double Blind, Multi Centric, Placebo Controlled, Single Dose, Phase I/II Study Assessing the Safety and Efficacy of Intravenous Ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cell in Patients with ST Elevated Acute MI (STEMI) Trial Completed.
44. Principal Investigator for RUBY 1Trial at The Heart Care Clinic /CIMS Ahmedabad (2010). A Randomized, Double Blind, Placebo Controlled, Multicentre and Parallel Group Study of the Safety, Tolerability, and Efficacy of YM150 in Combination with Standard Treatment in Secondary Prevention of Ischemic Vascular Events in Subjects with Acute Coronary Syndromes. Trial Completed.
45. Principal Investigator for AmarinTrial at The Heart Care Clinic/CIMS Ahmedabad (2010). A phase 3, Multi centre, Placebo Controlled, Randomized, Double Blind, 12 Week Study with an Open Label Extension to Evaluate the Efficacy and Safety of AMR101 in Patients with Fasting Triglyceride Levels

> 500 mg/dl and < 2000 mg/dl. Trial Completed.

1. Principal Investigator for AppraiseTrial at The Heart Care Clinic/CIMS Ahmedabad (2010). A Phase III, Randomized, Double Blind, Evaluation of the Safety and Efficacy of Apixaban in Subjects with a Recent Acute Coronary Syndrome. Trial Completed.
2. Co-Investigator for SAS HF Trial at The Heart Care Clinic/CIMS Ahmedabad (2008). South Asian Systolic Heart Failure Registry. Trail completed.
3. Co- Investigator for RELY ABLE study (2009). Long Term Multi-center Extension of Dabigatran Treatment in Patients with Atrial Fibrillation Who Completed the RELY Trial and a Cluster Randomized Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes. Trial completed.
4. Co-Investigator for TRAC HF Trial at The Heart Care Clinic/CIMS Ahmedabad (2009). TRAC HF: Ambulatory Monitoring Using External Physiological Sensors in Heart Failure Patients. Trial Completed.
5. Co-Investigator for DOT HF Trial at The Heart Care Clinic/CIMS Ahmedabad (2009). DOT-HF- Diagnostic Outcome Trial in Heart Failure. Trial Completed.
6. Co-Investigator for T BEST D Trial at The Heart Care Clinic/CIMS Ahmedabad (2009). T-BEST-D: Temporary Bronchial Epicardial Stimulation – Defibrillation Clinical Study Version dated: June 28, 2009. Trial Completed.
7. Principal Investigator for ALECARDIO Trial at The Heart Care Clinic/CIMS Ahmedabad (2010). A phase 3 Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled Study Cardiovascular Outcome Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients with a Recent Acute Coronary Syndrome (ACS) Event and Type 2 Diabètes Mellites (T2D). Trial Completed.
8. Co-Investigator for E Resolute Asia at CIMS Hospital, Ahmedabad (2010). Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Patient Population with Long Lesion(s) and/or Dual Vessels in Asia; Prospective, Multi-center, Non-randomized Study. Follow up Ongoing.
9. Principal Investigator for TIMI 52 Trial at The Heart Care Clinic / CIMS Ahmadabad (2010). A Phase 3 Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled Study of Darapladib versus Placebo in Subject Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events. Trial Completed.
10. Principal Investigator for SOLISTICE trial at CIMS Hospital Ahmadabad (2011). A Randomized

,Double-blind, Placebo-controlled Study to Evaluate the Safety of 12 Weeks of Dosing with GW856553 and its Effects on Inflammatory Markers, Infract Size, and Cardiac Function in Subjects with Myocardial Infarction without ST Segment Elevation. Trial Completed.

1. Principal Investigator for CANVAS study at CIMS Hospital Ahmadabad (2011). A Randomized. Double-blind, Parallel, Placebo-Controlled, Multicenter Study of the Effects of JNJ-28431754 on Cardiovascular Outcomes in Adult Subjects with Type 2 Diabetes Mellitus. The CANVAS Trial (Canagliflozin cardioVascular Assessment Study). Follow ups Ongoing.
2. Co-Investigator of study ATTAIN at CIMS Hospital Ahmadabad (2011). A Prospective, Non- randomized, Multi-center, Post-market, Global Clinical Trial to Assess Left-heart Lead Implant and Complication Rate Using the Medtronic Attain Family of Left-heart Leads and Delivery Catheters. Trial Completed.
3. Principal Investigator for TIMI 53 at CIMS Hospital Ahmadabad (2011). A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Sexagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patient with Type 2 Diabetes. Trial Completed.
4. Co-Investigator of study OPTIMIND at CIMS Hospital Ahmadabad (2011). Clinical Outcome of Pacemaker Patients According to Pacing Modality and Primary Indications. Trial Completed.
5. Co-Investigator of study SST at CIMS Hospital Ahmadabad (2011). The Pain Free SST (Smart Shock Technology) Clinical Study. Trial Completed.
6. Principal Investigator for VISTA 16 study at CIMS Hospital Ahmedabad (2011). Evaluation of the Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndrome (ACS).VISTA-16: Vascular Inflammation Suppression to Treat Acute coronary syndrome for 16 weeks. Trial                  Completed.
7. Principal Investigator for TAO study at CIMS Hospital Ahmedabad (2011). Randomized, Double- blind, Triple-dummy Trial to Compare the Efficacy of Otamixaban with Unfractionated Heparin + Eptifibatide, in Patients with Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive Strategy”. Trial Completed.
8. Principal Investigator for APOLLO study at CIMS Hospital Ahmedabad (2011). A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People Aliskiren Prevention Of Later Life Outcomes (APOLLO). Trial Completed.
9. Co-Investigator for DELIVER study at CIMS Hospital Ahmedabad (2011).DELiverability of Resolute Integrity Stent In all- Comer Vessels and Cross Over Stenting”. Trial Completed.
10. Principal Investigator for EPICOR ASIA study at CIMS Hospital Ahmedabad (2011). Long term follow up of antithrombotic management patterns In Acute Coronary Syndrome patients in Asia. Trial Completed.
11. Co- Investigator for REMOTE-EVIA study at CIMS Hospital Ahmedabad (2011). Registry for Pacemaker Offering Therapy Enhancement- EVIA. Trial Completed.
12. Principal Investigator for ABSORB Extend (2011) A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the treatment of Subjects with de novo Native Coronary Artery Lesions. Trial Completed.
13. Co- Investigator for IHRS study at CIMS Hospital Ahmedabad (2011). Indian Heart Rhythm Society (IHRS) Registry of Atrial Fibrillation: Patient Characteristics and Clinical Management Practices. Trial Completed.
14. Co-Investigator for Asian HF Registry at CIMS Hospital Ahmedabad (2012) Asian Sudden Cardiac Death in Heart Failure. Recruitment Ongoing.
15. Co-Investigator for PRISM at CIMS Hospital, Ahmedabad (2012). A Prospective Multi-Centre Registry to Investigate Safety and Effectiveness of M’Sure-S (Sirolimus Eluting Coronary Stent). Follow up Ongoing.
16. Co-Investigator for SureScan Pacing System Post-Approval Study at CIMS Hospital, Ahmedabad (2012). Trial Completed.
17. Co-Investigator for BISO-CAD(2012). A study to investigate the association between resting heart rate (HR) and prognosis of patients with Coronary Artery Disease (CAD) treated with bisoprolol . Trial completed.
18. Co-Investigator for IMPROVE-Brady study at CIMS Hospital, Ahmedabad (2012). Recruitment Ongoing.
19. Co-Investigator for Panorama 2 Registry at CIMS Hospital, Ahmedabad (2012). Medtronic CRDM Implantable Cardiac Device Long Term Registry. Follow up Ongoing
20. Principal Investigator for Medtronic Symplicity (2013) HTN-INDIA (CIP: 10054637DOC): Single- arm Study of Symplicity™ Renal Denervation System in Patients with Uncontrolled HyperTensioN in India – HTN-India. Trial Completed.
21. Co-Investigator for INSPIRE-ELR at CIMS Hospital, Ahmedabad (2013). – IdeNtifying High riSk Patients Post Myocardial Infarction with REduced Left Ventricular Function using External Loop Recorders. Follow up Ongoing.
22. Principal Investigator for CAD-PAD Registry at CIMS Hospital, Ahmedabad (2013). Coronary and Peripheral Artery Disease Registry. Trial Completed
23. Principal Investigator for A Double-blind, Randomized, Placebo controlled, multicenter study assessing the impact of additional LDL-Cholesterol reduction on Major cardiovascular events when AMG 145 is used in combination with statin therapy in patients with clinically evident cardiovascular disease. Study Completed.
24. Principal Investigator for To Evaluate The Role Of Radiation Protection Technology (Cardiotrap^TM) In Improving Radiation Safety In Diagnostic And Interventional Percutaneous Cardiology Procedures. Investigator Initiated Study. Recruitment Ongoing.
25. Co- Investigator for Safety and Efficacy of Axiostat^® hemostatic dressing on radial access after percutaneous procedure: A comparative open label study. Investigator Initiated Study. Recruitment Ongoing.
26. Co- Investigator for A Phase III, International, Multi-Centre, Randomized, Double-Blinded, Placebo- Controlled, Clinical Worsening study of UT-15C in Subjects with Pulmonary Arterial Hypertension Receiving Background oral Monotherapy. Recruitment Ongoing.
27. Co- Investigator for An Open-Label Extension study of UT- 15C in subjects with Pulmonary Arterial Hypertension – A Long-Term Follow up to Protocol TDE-PH-310. Recruitment Ongoing.
28. Co – Investigator for A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus. Follow up Ongoing.
29. Co – Investigator for A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes. Follow up Ongoing.
30. Co-Investigator for TWILIGHT-Ticagrelor with Aspirin or alone in high risk patients after coronary intervention. Recruitment Ongoing.
31. Co-Investigator for REDUAL-PCI at CIMS Hospital, Ahmedabad (2014). A prospective Randomised, open label, blinded endpoint (PROBE) study to Evaluate DUAL antithrombotic therapy with dabigatran etexilate (110mg and 150mg b.i.d.) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with non valvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting (RE-DUAL PCI). Follow up Ongoing.
32. Co-Investigator for Improve SCA at CIMS Hospital, Ahmedabad (2014). For Improve Sudden Cardiac Arrest study. Recruitment Ongoing.
33. Co-Investigator for REPORT HF at CIMS Hospital, Ahmedabad (2014).International Registry to assess mEdical Practice with lOngitudinal obseRvation for Treatment of Heart Failure. Follow up Ongoing.
34. Co-Investigator for Declare at at CIMS Hospital, Ahmedabad (2014) – A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes.
35. Co-Investigator for Themis at CIMS Hospital, Ahmedabad (2014) A Multinational, Randomized, Double-Blind, Placebo controlled Trial to Evaluate the Effect of Ticagrelor 60 mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus
36. Co-Investigator for PRA PH – 311 at CIMS Hospital, Ahmedabad (2014) “An Open-Label Extension Study of UT-15C in subjects with Pulmonary Arterial Hypertension – A Long-Term Follow-Up to Protocol TDE-PH-310”.
37. Co-Investigator for Resolute Asia at CIMS Hospital, Ahmedabad (2015) – Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Patient Population with Long Lesion(s) and/or Dual Vessels in Asia .A Prospective, Multi-center, Non-randomized Study
38. Co-Investigator for Twilight at CIMS Hospital, Ahmedabad (2015)Ticagrelor with Aspirin or alone in high risk patients after coronary intervention
39. Co-Investigator for Merk-HF at CIMS Hospital, Ahmedabad (2016) Protocol Title: “A prospective, open label, multi-centric, observational registry for heart failure patients across India.
40. Co-Investigator for Redual PCI at CIMS Hospital, Ahmedabad (2016) – A prospective Randomised, open label, blinded endpoint (PROBE) study to Evaluate dual antithrombotic therapy with dabigatran etexilate (110mg and 150mg b.i.d.) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with non valvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting
41. Principal Investigator for Morph India Redual PCI at CIMS Hospital, Ahmedabad (2016) – A prospective, single-arm, multi-centre, observational, real world, post-marketing surveillance to evaluate safety and performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for very long coronary lesions.
42. Co-Investigator for More CRT MPP at CIMS Hospital, Ahmedabad (2016) – MOre REsponse on Cardiac Resynchronization Therapy (CRT) with Multipoint Pacing (MPP)
43. Co-Investigator for DAPA HF at CIMS Hospital, Ahmedabad (2018) – Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening HF or Cardiovascular Death in Patients with CHF with Reduced Ejection Fraction
44. Co-Investigator for Asia MRI at CIMS Hospital, Ahmedabad (2018) – A post-market clinical evaluation of St. Jude Medical^TM MR Conditional ICD System on patient undergoing Magnetic Resonance Imaging
45. 100.Co-Investigator for Asia MRI at CIMS Hospital, Ahmedabad (2018) – OBTURA^TM VCD-PMS: A Prospective, Single-Blind, Multi-Center, Randomized, Post Marketing Clinical Study Comparing OBTURA^TM vascular closure device versus manual compression to evaluate safety and performance in patients who have undergone femoral artery puncture procedure.
46. 101.Co-Investigator for Paradise MI at CIMS Hospital, Ahmedabad (2018) – A multi-center, randomized, double-blind, active-controlled, parallel-group Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to ramipril on morbidity and mortality in high risk patients following an acute myocardial infarction
47. 102.Co-Investigator for PARALLEX at CIMS Hospital, Ahmedabad (2018) – “A 24-week, randomized, double-blind, multi-center, parallel group, active controlled study to evaluate the effect of LCZ696 on NT-proBNP, symptoms, exercise function and safety compared to individualized medical management of comorbidities in patients with heart failure and preserved ejection fraction”.
48. 103.Co-Investigator for SELECT at CIMS Hospital, Ahmedabad (2018) – Semaglutide effects on cardiovascular outcomes in people with overweight or obesity
49. 104.Co-Investigator for MyVal-1 at CIMS Hospital, Ahmedabad (2018) – A prospective, multicentric, single arm, open label study of MyValTM Transcatheter Aortic Valve Replacement System in the treatment of severe symptomatic native aortic valve stenosis”.
50. 105.Co-Investigator for CTQJ230A12001 at CIMS Hospital, Ahmedabad (2019) – Multi-center cross- sectional epidemiological study to characterize the prevalence and distribution of lipoprotein (a) levels among patients with established cardiovascular disease
51. 106.Co-Investigator for CTQJ230A12301 at CIMS Hospital, Ahmedabad (2020) – A randomized double- blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease.
52. 107.Principal Investigator for Dare 19 at CIMS Hospital, Ahmedabad (2020) “An International, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Dapagliflozin in Respiratory Failure in Patients with COVID-19” (DARE 19)
53. 108.Principal Investigator for I8F-MC-GPGN(b) at CIMS Hospital, Ahmedabad (2020) – The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes (SURPASS-CVOT)

NATIONAL CLINICAL TRIALS

1. Principal Investigator for BIVAFLO Registy (2006). To evaluate the Efficacy and Safety of BIVAFLO^® as an Adjunctive Therapy During PCI in Moderate-high Risk ACS Patients with Provisional GP IIb/IIIa Inhibitors Use. (Completed)
2. Principal Investigator for CORREL + C Trial (2006). The COREL C Registry: A Multicentre Post Marketing Surveillance for Clinical and Angiographic Evaluation of Corel C Stent. (Completed)
3. Principal Investigator for POLYCAP Trial at The Heart Care Clinic/CIMS Ahmedabad (2007). A Randomized Double blind controlled trial of the efficacy And safety of POLYCAP Vs its components in subjects With at least one additional cardiovascular risk factor. (Completed)
4. Principal Investigator for ACUNOVA Trial (2006-2007). A phase III, open label, multi-centric, parallel group, Randomized study to evaluate the safety and efficacy of Abciximab in Indian patients scheduled for Percutaneuos Coronary Intervention. (Completed)
5. Co – Investigator for ZYHI Trial at The Heart Care Clinic Ahmedabad (2007) Trial Completed.
6. Co-Investigator for “The Dyslipidemia REMAINS Study” – A multicenter, prospective, observational study of lipid profiles and treatment patterns at presentation and after 12 weeks of statin therapy among Indian adults presenting with first coronary event, ongoing at CIMS Hospital Ahmedabad (2012).
7. Principal Investigator for HF-Registry at CIMS Hospital, Ahmedabad (2012). A prospective, open label, multi-centric, observational registry for heart failure patients across India.
8. Co- Investigator for “The International Polycap Study 3” (TIPS 3) at CIMS Hospital, Ahmedabad (2012) – A randomized double-blind placebo-controlled trial for the evaluation of a polycap, low dose aspirin and vitamin D supplementation in primary prevention.
9. Co – Investigator for Prism at CIMS Hospital, Ahmedabad (2014) A Prospective Multi-Centre Registry to Investigate Safety and Effectiveness of M’Sure-S (Sirolimus Eluting Coronary Stent)
10. Principal Investigator for TREASURE at CIMS Hospital, Ahmedabad (2015).A non-inTeRventional prospEctive observationAl Study to Understand the usage pattern of Ticagrelor in Indian patients with acute coronaRy syndromE (TREASURE).
11. Co – Investigator for Treasure at CIMS Hospital, Ahmedabad (2015) – A non-interventional prospective observational Study to Understand the usage pattern of Ticagrelor in Indian patients with acute coronary syndrome
12. Co – Investigator for Improve Vrady-2 at CIMS Hospital, Ahmedabad (2015) -Sinus node dysfunction registry phase 2
13. Principal Investigator for BioMime Morph at CIMS Hospital, Ahmedabad (2016). A prospective, single-arm, multi-centre, observational, real world, post-marketing surveillance to evaluate safety and performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for very long coronary lesions.
14. Principal Investigator for Study Protocol No: MOZEC SEB PTCA PMS – 1 at CIMS Hospital, Ahmedabad (2017) Protocol Title: A prospective, multi-center, real world, post marketing surveillance (PMS) to evaluate safety and performance of the MOZEC Sirolimus Eluting Percutaneous Transluminal Coronary Angioplasty Balloon Dilatation Catheter for In-Stent Restenosis (ISR) or de novo  coronary arteries in daily clinical practice.
15. Co – Investigator for Axiostat at CIMS Hospital, Ahmedabad (2016) – Safety and Efficacy of Axiostat hemostatic dressing on radial access after percutaneous procedure: A comparative open label study
16. Principal Investigator for Cardiotrap at CIMS Hospital, Ahmedabad (2016) – To Evaluate The Role Of Radiation Protection Technology (Cardiotrap^TM) In Improving Radiation Safety In Diagnostic And Interventional Percutaneous Cardiology Procedures
17. Principal Investigator for COR10649 at CIMS Hospital, Ahmedabad (2018) “Effectiveness and Safety of Optical Coherence Tomography- Guided PCI in Indian Patients with Complex Lesions- A Multicenter, Prospective Registry”
18. Co – Investigator for MANDATE AF at CIMS Hospital, Ahmedabad (2019) Management of Device detected Atrial Tachyarrhythmia and Impact of Device treatment algorithms on Atrial Fibrillation in Indian population – “study”
19. Co – Investigator for NVAF at CIMS Hospital, Ahmedabad (2020) A Real-World, Prospective, observational Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto®) for prevention of Stroke and Systemic Embolism in Indian patients with Non-valvular Atrial Fibrillation (NVAF)

• NATIONAL & INTERNATIONAL PUBLICATIONS

1. Uri Elkayam, Keyur Parikh, Shahbudin Rahimtoola. Absence of effect of Diltiazem on Digoxin Serum Concentration and Renal clearance in Patients with Cardiac Disease. JACC, 1985 Vol 5, No.2, Part 2 Page 419(Abstract)
2. Uri Elkayam, Keyur Parikh, Behrooz Torkan, Laura Weber, Jorden Cohen, Shahbudin Rahimtoola. Effect of Diltiazem on Renal Clearance and Serum Concentration of Digoxin in Patients with Cardiac Disease. Am J Cardiol http://www.ncbi.nlm.nih.gov/pubmed/39935761985;55(11):1393-5.
3. Keyur Parikh, Peter Mahrer , Amar Kapoor, Kaiser Hospital, Los Angeles. Subsets of Left Main Coronary Artery Disease: Clinical and Impact on Artery Disease: Clinical and Impact on Survival Correlating with Angiographic Data . 1985-1987.
4. Keyur Parikh, Peter Mahrer, Kaiser Hospital, Los Angeles. Clinical Profiles of Atrial Myxomas. Cardiovascular Review And Reports (1987)
5. K H Parikh et al. Use of Abciximab (Reopro): In High Risk Coronary Artery Disease Patients During Angioplasty and Stents. Gujarat Medical Journal 1999;56:1.
6. K H Parikh. HCPR Guidelines for Heart Failure Therapeutics. Indian Heart J 2000; 52(6):668-830.
7. K H Parikh (CSI). Ischemic Heart Disease Endothelial Dysfunction. Indian Heart J 2000; 52(6):668- 830.
8. Keyur Parikh (CSI). Gujarat Earthquake – A Cardiologist’s Perspective. Indian Heart J 2000; 52(6):668-830.
9. Parikh KH, Chag M C, Shah UG, Baxi HA, Chandarana AH, Naik A M, Shah KJ. Acute Results and Intermediate term Follow-up of PCI with Cardio Protection by Balloon Occlusion Distal Protection Device (Abstract). Indian Heart J-233, 2002 54:561-568.
10. Shah H, Iyer S, Mehta K, Parikh K, Jain A, Goyal RK. Pharmaco-epidemology and Risk Factors of Hypertension in Western Gujarat (Abstract). Indian Journal of Pharmacology 2003; 35(4);277.
11. Shah KJ, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Prevalence of Hyper–homocysteinemia in Western Indian Population with or Without Coronary Artery Disease Indian Journal of Cardiology 2003;6:54-58.
12. Parikh KH, Shah KJ, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Reversal of Slow-Flow or No-Reflow During PTCA Using Boluses of IC Adenosine and Sodium Nitroprusside in Combination. Suppl. To JACC, Mar 19, 2003; 41(6), Suppl.A-1101-201.
13. Parikh KH,Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah HD, Goyal RK. Beneficial Effects of Distal Protection Device in Reducing the Use of Intracoronary Vasodilators and Glycoprotein IIb/IIIa Receptor Antagonists During Percutaneous Coronary Interventions. Catheterization and Cardiovascular Interventions 2004;62:90. (Abstract)
14. Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Revascularization in Acute Myocardial Infarction Using Percusurge in Distal Protection (RAPID) (Abstract). Catheterization and Cardiovascular Interventions 2004;62:116.
15. Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah HD, Goyal RK. Improvement in MACE by Sequentia Administration of Boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. Catheterization and Cardiovascular Interventions2004;62:130-131.
16. Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah HD, Shah KJ, Shah JN, Goyal RK. Improvement in MACE by Sequential Administration of Boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. ESC Congress 2004: Abstract: P3045.
17. Chag MC, Parikh KH, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah HD, Shah KJ, Goyal RK. Increased Lipoprotein as a Strong Risk Factor for Coronary Artery Disease and the Effect or Niacin Amongst Indians. Indian Heart J 2004;56(5):377-599.
18. Chag MC, Shah HD, Joshi MV, Parikh KH, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Goyal RK. Renal Artery Stenting is Safe and Effective Modality of Treatment on Mid-term Follow-up. Indian Heart J 2004;56(5):377-599.
19. Shah KJ, Chag MC, Parikh KH, Goyal RK. Homocysteine and Coronary Artery Disease. Indian Journal of Pharmaceutical Sciences 2004;66:595-601.
20. Shah HD, Iyer S, Shah K, Parikh K, Chag M, Shah U, Baxi H, Chandarana A, Naik A, Goyal RK. Effect of Statins in Combination with Fenofibrate in Patients after Percutaneous Transluminal Coronary Angioplasty. Indian Journal of Pharmacology 2004;36(2):113.
21. Shah KJ, Parikh KH, Goyal RK. Bosentan in Primary Pulmonary Hypertension. Indian Journal of Pharmacology 2004;36(2):118.
22. Mehta KN, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study. Indian Journal of Pharmacology 2005;37:13-17.
23. Shah KJ, Iyer SS, Parikh KH, Goyal RK. Dual RAAS Blockade with ACE-I and ARB. Indian Journal of Cardiology
24. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK. Association of White Blood cell count with the Occurrence of slow/no reflow in acute coronary Syndrome patients undergoing PCI. Poster presentation at Joint International Conference of ISHR and IACS, Jan 2005, Gujarat, India.
25. Shah HD, Parikh KH, Goyal RK. Recent Trends in Antiplatelet Therapy for Acute Coronary Syndromes: Glycoprotein IIb/IIIa Receptor Antagonists. Gupta SK, Pawan Singhal PK, Agrawal SS, Pharmacotherapy of Heart failure, Ch 8,102:22, 2005.
26. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK. Efficacy of Percusurge Guardwire system in acute Myocardial patients undergoing Primary/rescue PCI. Oral Presentation at Joint International Conference of ISHR and IACS, Jan 2005, Gujarat, India.
27. Parikh KH, et al. Development of Group Practice in Cardiology, Financial Planning and Research and Development. CSI Book 2005.
28. Kanan Shah, Keyur Parikh, Milan Chag, Urmil Shah, Anish Chandarana, Hemang Baxi, Ajay Naik, Ramesh K. Goyal. A Vigilance Study of Distal Protection Device Used During Percutaneous Coronary Interventions. International Journal of Risk & Safety in Medicine 2006;18(4):205-212.
29. KH Parikh, HA Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN Shah, MP Tanna, MC Chag. Initial Clinical Experience with Bivalirudin as an Anticoagulant During Percutaneous Coronary Interventions in Asian Indian Patients. Indian Heart J 2006;58(5):384-498.
30. KH Parikh, HA Shah, JN Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, RK Goyal, MC Chag. Prospective Randomized Study of PercuSurge in Acute Myocardial Infarction Patients Undergoing Revascularization with a Special Emphasis on Procedural Time: A Two Year Follow-up. Indian Heart J 2006;58(5):384-498.
31. Chandarana AH, Shah JN, Shah HA, Shah UG, Baxi HA, Naik AM, Joshi M, Goyal RK, Parikh KH, Chag MC. High Prevalence of Renal Artery Stenosis in Hypertensive Patients with Triple Vessel Coronary Artery Disease: Recommendation For Simultaneous Renal Arteriogram for Earlier Intervention. Indian Heart J 2006;58(5):384-498.
32. HA Shah, JN Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, AM Naik, KH Parikh, RK Goyal. Association between the White Blood Cell Count and Occurrence of Slow or No Reflow Phenomenon in Patients with Acute Coronary Syndromes in the Coronary Interventional Era. Indian Heart J 2006;58(5):384-498.
33. HA Shah, MC Chag, MP Tanna, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN Shah, KH Parikh.. Incidences and Clinical Characteristics of No Reflow after Percutaneous Coronary Interventions in High Risk Asian Indian Patients. Indian Heart J 2006;58(5):384-498.
34. Keyur H. Parikh. Using the Remon Pressure Device: One Year Follow-up. Presented at Innovations in Cardiovascular Interventions (ICI), Israel, 2006.
35. KH Parikh, AM Naik, HA Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, JN Shah, A Medina, S Banai. First In Man: Direct Comparison of Conventional Coronary Sinus Angiography and CT Angiography for Visualization and Sizing of Coronary Sinus. Presented at TCT- October 2006, Washington DC.
36. KH Parikh, HA Shah, AH Chandarana, AM Naik, MC Chag, UG Shah, HA Baxi, JN Shah, A Medina, S Banai. First In Man: Multislice CT Angiography Visualization Of An Innovative First-in-man Coronary Sinus Reducer Stent In Patients With Refractory Angina. Presented at TCT- October 2006, Washington DC.
37. Parikh KH, Shah HA. A Year in Percutaneous Interventions. Published In Cardiology Update 2006.
38. Parikh KH, Shah HD, et al. Stem Cell Therapy in ACS; Type, Timing and Promise. The Post-Graduate Medicine, 2006.
39. KH Parikh, HA Shah, AM Naik, HA Baxi, MC Chag, AH Chandarana, A Hjalmarson, Y Rozenman. First In Man: Measurement of Diurnal Variation in Pulmonary Artery Systolic and Diastolic Pressure in Heart Failure Patients Using an Innovative Implantable Device Responding to Ultrasonic Signals. Eur Heart J (2006) 27(suppl 1) 291-565. Abstract Number: P2949.
40. KH Parikh, HA Shah, AM Naik, HA Baxi, MC Chag, UG Shah, A Hjalmarson, Y Rozenman. First in Man: non invasive measurement of variation in Pulmonary artery pressure following exercise in heart failure patients using an innovative implantable device involving acoustic telemetry. Eur Heart J (2006) 27(suppl 1) 827-985. Abstract Number: 5413.
41. KH Parikh, HA Shah, AM Naik, HA Baxi, MC Chag, AH Chandarana, A Hjalmarson, Y Rozenman. First In Man: Effect of Metoprolol CR/XL on Exercise Capacity and Subsequent Variation in Pulmonary Artery Pressure in Heart Failure Patients Using an Innovative Implant Involving Acoustic Telemetry. Eur Heart J (2006) 27(suppl 1) 827-985. Abstract Number: P5412.
42. KH Parikh, AM Naik, HA Shah, HA Baxi, MC Chag, UG Shah, AH Chandarana, Y Rozenman. First In Man Non-Invasive Monitoring of Pulmonary Artery Pressure from an Implantable Device Using Acoustic Telemetry: A One Year Follow-Up Data. Eur Heart J (2006) 27(suppl 1) 1-290. Abstract Number: P1363.
43. MC Chag, HA Shah, AM Naik, HA Baxi, UG Shah, AH Chandarana, Y Rozenman, KH Parikh. First- In-Man: Comparison of Impressure Device Measuring Pulmonary Artery Pressure Non-invasively with Conventional Contrast Echocardiography in Congestive Heart Failure. Eur Heart J (2006) 27(suppl 1) 1-290. Abstract Number: P1364.
44. HA Shah, RK Goyal, AM Naik, HA Baxi, MC Chag, A Hjalmarson, Y Rozenman, KH Parikh. First In Man Study: Effect of Metoprolol CR/XL on Diurnal Variation in Pulmonary Artery Pressure Assessed Non-invasively Using an Innovative Implantable Device Responding to Ultrasonic Signals. Eur Heart J (2006) 27(suppl 1) 291-565. Abstract Number: P2158.
45. Parikh KH, Shah HP, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Rozenman Y. First in man: Papirus-monitoring Pulmonary artery Pressure by Implantable device Responsible to Ultrasonic signals. Oral Presentation at the Late Breaking Clinical Trials Session at the ACC-i2 summit, ACC Conference, March-12, 2006.
46. Banai S, Keren G, Sievert H, Seth A, Ben Muvhar S, Naik AM, Medina A, Chandra P, Shah H, Parikh KH. First-in-man: Coronary Sinus Narrowing with a Reducer Stent- A Possible Alternative Percutaneous Treatment for Patients with Refractory Angina. J Am Coll Cardiol 2006;47;1B-56B. Abstract Number: 2909-121.
47. Parikh KH, Shah HP, Naik AM, Chag MC, Shah US,Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Rozenman Y. Effect of Metoprolol XL on pulmonary artery pressure in patients

with heart failure measured using first in human implantable Device responding to ultrasonic signal. Presented in Poster session at ACC Conference on March 12, 2006. Atlanta.

1. Parikh KH, Shah HP, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Razenman Y. First in Human Implanted Device in Pulmonary Artery Using Acoustic Telemetry Based on Non-Invasive Ultrasound Activation and Communication. J Am Coll Cardiol 2006;47;1B-56B. Abstract Number: 2926-71.
2. Shah HD, Goyal RK, Parikh KH. Intraconory Boluses of Adenosine and Sodium Nirtoprusside in combination Reverses Slow/No Reflow During Angioplasty: A Clinical Scenario of Experimental Pre- conditioning. J Am Coll Cardiol 2006;47:381A-384A. Abstract Number: 408-9.
3. Parikh KH, Shah HD, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Rozenman Y. Effect of Metaprolol XL on Diurnal variation inpulmonary arterial pressure in Heart failure patients using first-in-man implantable device responding to ultrasonic signals. Presented in Poster session at ACC Conference on March 14, 2006. Atlanta.
4. Hetal A Shah, Ajay M Naik, Hemang A Baxi, Milan C Chag, Urmil G Shah, Anish H Chandarana, Ramesh K. Goyal, Yoseph Rozenman, Keyur H Parikh. First-in-man: effect of Metoprolol CR/XL Uptitration on Pulmonary Artery Pressure and Its Variation in Chronic Heart Failure Monitored Non- Invasively by an Implanted Device Using Ultrasonic Signals. European Heart Journal (2007) 28 (Abstract Supplement), 521.
5. Yoseph Rozenman, Robert S, Schwartz, Hetal Shah, Keyur H. Parikh. Wireless Acoustic Communication with a Miniature Pressure Sensor in the Pulmonary Artery for Disease Surveillance and Therapy of Patients with Congestive Heart Failure. J Am Coll Cardiol 2007;49:784–789.
6. Shmuel Banai, Shmuel Ben Muvhar, Keyur H Parikh, Aharon Medina, Horst Sievert, Ashok Seth, Jonathan Tsehori, Yoav Paz, Ami Sheinfeld, Gad Keren. Coronary Sinus Reducer-Stent for the Treatment of Chronic Refractory Angina Pectoris: A Prospective, Open Label, Multi-Center Safety Feasibility First-In-Man Study. J Am Coll Cardiol 2007;49:1783-1789.
7. Parikh KH, Chag MC, Shah KJ, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah HD, Goyal RK. Intracoronary Boluses of Adenosine and Sodium Nitroprusside in Combination Reverses Slow/No-Reflow During Angioplasty: A Clinical Scenario of Ischemic Preconditioning. Can J Physiol Pharmacol. 2007;85(3-4):476-82.
8. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Iyer S, Goyal RK. Beneficial Effects of Addition of Fenofibrate to Statin Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Interventions. Exp Clin Cardiol 2007:12:91- 6.
9. Mehta A, Shah U, Parikh K, Chag M, Baxi H, Chandarana A, Naik A, Shah K, Goyal R. Effect of Pioglitazone and its Combination with Statins in Coronary Artery Disease Patients with Hyperinsulinemia. Can J Physiol Pharmacol 2007;85(6):628-33.
10. Goyal RK, Parikh KH, Shah HA. First –In-Man Clinical Trials in India. CV network online 2007;6:44- 7.
11. Parikh KH, Shah HA. Investigational Treatments and Future Directions in Heart Failure. Investigational Treatments and Future Directions in Heart Failure. Cardiology Today 2007;12:96-103.
12. Parikh KH, Tanna MT, Shah HA, Shah AR. Basics of Stem Cell Therapy in Heart Failure. Cardiology Today 2007;12:104-114.
13. Goyal RK, Parikh KH, Shah HA. An Overview on the Management of Chronic Refractory Angina Pectoris. Proceedings of International Symposium on RACS 2008;135-153.
14. Parikh KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Goyal RK. Efficacy of PercuSurge in Acute myocardial Infarction Patients Undergoing Revascularization With a Special Emphasis on Procedural Time. Indian Heart J 2008; 60(2):101-19.
15. Nakul Sinha, Keyur Parikh, Jaysheel B. Gangaiah, Alok Chaturvedi. Randomized, Multi-centric, Open Label Study to Evaluate Safety and Efficacy of Faximab^®, A Biosimilar Abciximab in Indian Patients Undergoing Percutaneous Coronary Intervention. Submitted to Indian Heart Journal in August 2008.
16. Keyur Parikh, Milan Chag, Urmil Shah, Anish Chandarana, Hemang Baxi, Satya Gupta, Ashok Seth, Pravin Chandra. First in Man: Pilot study to evaluate the safety and performance of Diamondback 360°^TM Orbital Atherectomy System in treating de novo calcified coronary lesions-ORBIT I. Submitted to TCT,2008 as Late Breaking Trial.
17. Ashok Seth, Nakul Sinha, Keyur Parikh, Tejas Patel, MS Hiremath, AB Mehta, Praveen Chandra, Brian Pinto, KK Sethi, Sengottuvelu. Safety and Efficacy of Indigenously Developed and Manufactured Bivalirudin in Moderate/High-Risk Indian Patients Undergoing Percutaneous Coronary Intervention: The Bivaflo Registry. Indian Heart J 2008;60(4):333-41.
18. Keyur H Parikh. First Report of a pilot study of orbital atherectomy in de novo calcified coronary lesions. Accepted in TCTMD in Oct. 2008 (www.tctmd.com).
19. Keyur H Parikh. FIM Coronary CTO Results. Accepted in TCTMD in Oct. 2008 (www.tctmd.com)
20. Keyur H Parikh. PAPIRUS Monitoring Pulmonary Artery Pressure by the Implantable Device Responding to Ultrasonic Signals-Two Year Follow Up. Accepted in TCTMD in Oct. 2008 (www.tctmd.com).
21. Chevalier B, Gilard M, Lang I, Commeau P, Roosen J, Hanssen M, Lefevre T, Carrié D, Bartorelli A, Montalescot G, Parikh K. Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter. Eurointerv 2008;4:222-228.
22. Parikh KH, Chag Milan, Shah Anuja, Segev Amit. Ovalum CiTop^TM: A Novel Guidewire for Crossing Chronic Total Occlusion – First-in-Man (FIM) Experience. EuroInterv 2009;5:206-211.
23. Parikh KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK, Rozenman Y, Hjalmarson A. Effect of Metoprolol CR/XL on Pulmonary Artery Pressure in Chronic Heart Failure Patients Assessed by an Implanted Ultrasonic Device with Special Emphasis on Diurnal Variation and Exercise Capacity. Indian Heart J 2009;61:34-9.
24. Keyur Parikh, Ashok Seth, Hemang Baxi, Anish Chandarana, Satya Gupta, Urmil Shah, Milan Chag, Sandhya Nair, Praveen Chandra. First In Man Assessment of Orbital Atherectomy System in Treating De Novo Calcified Coronary Lesions (ORBIT I). J Am Coll Cardiol 2009;53;A1-A99. Abstract Number: 2502-557.
25. Keyur Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chanadarana, Ajay Naik, Satya Gupta, Shmuel Banai. Long Term Safety, Angina Relief and Improvement in Quality of Life in Patients with Refractory Angina Treated with the Neovasc Coronary Sinus Reducer. J Am Coll Cardiol 2009;53;A1- A99. Abstract Number: 2502-550.
26. Keyur Parikh, Milan Chag, Amit Segev, Anuja Shah. FIM Study: The Ovalum CiTop Expander Guidewire for Recanalisation of Coronary CTOs. Euro Intervention 2009;5(Supplement E):E99.
27. Ian Meredith, Martin Rothman, Andrejs Erglis, Keyur Parikh, Chaim Lotan. Safety and Effectiveness of the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice: Extended 2-Year Follow- up from the E-Five Registry. J Am Coll Cardiol Intv 2009;2;1227-1235.
28. Robert A. Harrington, Gregg W. Stone, Steven McNulty, Harvey D. White, A. Michael Lincoff, C. Michael Gibson, Charles V. Pollack, Jr., Gilles Montalescot, Kenneth W. Mahaffey, Neal S. Kleiman, Shaun G. Goodman, Maged Amine, Dominick J. Angiolillo, Richard C. Becker, Derek P. Chew, William J. French, Franz Leisch, Keyur H. Parikh, Simona Skerjanec, and Deepak L. Bhatt. Platelet Inhibition with Cangrelor in Patients Undergoing PCI. N Engl J Med 2009;361:2318-29.
29. Edoardo Camenzind, William Wijns, Laura Mauri, cEric Boersma, Keyur Parikh, Volkhard Kurowski, Runlin Gao, Christoph Bode, John P. Greenwood, Anthony Gershlick, William O’Neil,

Patrick W. Serruys, Brenda Jorissen, and Gabriel P. Steg. Rationale and Design of the Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial (PROTECT): Randomized Controlled Trial Comparing the Incidence of Stent Thrombosis and Clinical Events after Sirolimus or Zotarolimus Drug- Eluting Stent Implantation. Am Heart J 2009;158:902-909.e5.

1. Jagdish Hiremath, S. Thanikachalam, Keyur Parikh, S. Shanmugasundaram, Sudhakar Bangera, Leland Shapiro, Gregory B. Pott Cindy L.Vnencak-Jones. Exercise Improvement and Plasma Biomarker Changes with Intravenous Treprostinil Therapy for Pulmonary Arterial Hypertension: A Placebo-Controlled Trial (TRUST – 2) The Journal of Heart and Lung Transplantation 2010;29(2):137- 149.
2. Patel HR, Patel MV, Ghatak SB, Anand IS, Parikh KH, Bhatt PA. Study to Evaluate Safety and Efficacy of Bare Metal Stent and Zotarolimus Eluting Stent. Poster Session at the 61st Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the Nirma University of Science and Technology, Ahmedabad, India.
3. Bhanushali SM, Patel VD Ghatak SB, Patel MV, Daniel PS, Parikh KH, Bhatt PA. To evaluate the comparative efficacy of angiotensin receptor blocker in acute coronary syndrome patients following medicated and non-medicated coronary stent implantation. Poster Session at the 61st Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the Nirma University of Science and Technology, Ahmedabad, India.
4. Patel VD, Patel MV, Ghatak SB, Anand IS, Parikh KH, Bhatt PA. Triple versus dual antiplatelet therapy following coronary stenting: Impact on lipid profile. Poster Session at the 61st Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the Nirma University of Science and Technology, Ahmedabad, India.
5. Patel JM, Patel HR, Patel MV, Ghatak SB, Anand IS, Parikh KH, Bhatt PA. Pharmacoeconomic analysis, clinical outcomes and quality of life assessment between medication therapy and drug eluting stent in single vessel blockade patients. Poster Session at the 61st Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the Nirma University of Science and Technology, Ahmedabad, India.
6. Parloop Bhatt, Manoj Patel, Somsuvra Ghatak, Keyur Parikh. Reinventing the Phases of Clinical Trial. Pharmaceutical Reviews 2010;8(1).
7. Camenzind E, Steg PG, Parikh K, Kurowski V, Gao R, Bode C, Greenwood JP, Gershlick A, Boersma E, Mauri L, O’Neill W, Serruys PW, Wijns W. Baseline Clinical and Angiographic Characteristics of the Patient Related Outcomes WiTh Endeavor Versus Cypher STenting (PROTECT) Trial. J Am Coll Cardiol 2010;56;B64.
8. Shmuel Banai, Marc Schwartz, Horst Sievert, Ashok Seth, Gad Keren, Keyur H Parikh. Long Term Follow-Up to Evaluate the Safety of the Neovasc Reducer A Device-Based Therapy for Chronic Refractory Angina. J Am Coll Cardiol 2010;55;A98.E927.
9. Hiren patel, Manoj Patel, I. S.Anand, Chaman Patel, Keyur Parikh, Parloop Bhatt. Pharmacoeconomical Comparison of Bare Metal Stent and Drug Eluting Stent. Journal of Chemical and Pharmaceutical Research 2010;2(2):73-81.
10. Jatin Patel, Vinod Patel, Hiren Patel, Manoj Patel, Keyur Parikh, Parloop Bhatt, Chaman Patel, I. Anand. Pharmacoeconomic Analysis, Clinical Outcomes between Medication Therapy and Drug Eluting Stent in Single Vessel Blockade Patients. Deccan Journal of Pharmacology 2010; 1(1):29•42.
11. Hiren R Patel, Vinod D Patel, IS Anand, CN Patel, Keyur Parikh, Parloop Bhatt. A Study to Compare Clinical Outcomes of Bare Metal Stent and Zotarolimus Eluting Stent. Journal of Global Pharma Technology 2010;2(3):146-153.
12. Sandip Bhanushali, PS Daniel, IS Anand, CN Patel, Parloop Bhatt, Keyur Parikh. The Comparative Efficacy of Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Following

Medicated and Non-medicated Stent Implantation. Journal of Global Pharma Technology 2010;2(3):98–106.

1. Vinod Patel, J M Patel, I S Anand, C N Patel, M V Patel, Keyur Parikh, Parloop Bhatt. Triple Versus Dual Antiplatelet Therapy Following Coronary Stenting: Impact on Lipid Profile. Deccan Journal of Pharmacaology 2010;1(1):43•59.
2. Keyur Parikh. Editorial: A Quarter Century of Direction- Femoral Approach Towards Extinction…. Indian Heart Journal 2010;62(3):191.
3. Keyur Parikh. Guest Editorial. Gujarat Medical Journal 2010;5(7):13.
4. Parikh Keyur, Parikh Roosha. Guidelines (and Advisory) for Doctors and surgeons) to Manage Anti- thrombotic Agents in Patients with Drug Eluting and Bare Metal Stents Undergoing Non Cardiac Surgery. Gujarat Medical Journal 2010;5(7):49-53.
5. Parikh Keyur, Naik Ajay, Gupta Satya, Baxi Hemang, Chandarana Anish, Shah Urmil, Chag Milan. RemonCHF: Better Care for Congestive Heart Failure Patients. Gujarat Medical Journal 2010 Jul;5(7):109-110.
6. Naik Ajay, Chandarana Anish, Chag Milan, Gupta Satya, Baxi Hemang, Shah Urmil, Parikh Keyur. Neovasc Coronary Sinus Reducer: The Time Tested Option for “No Option” Patients. Gujarat Medical Journal 2010;5(7):111-113.
7. Parikh Keyur, Pandya Nilesh, Baxi Hemang, Chag Milan, Gupta Satya, Chandarana Anish, Naik Ajay, Shah Urmil. The Principal Investigator of ORBIT I Trial Discusses Safety and Performance of Diamondback 360° TM Orbital Atherectomy System in Treating de novo Calcified Coronary Lesions. Gujarat Medical Journal 2010;5(7):114-116.
8. Chag Milan, Panchal Kanaiya, Baxi Hemang, Chandarana Anish, Naik Ajay, Shah Urmil, Parikh Keyur. Initial Experience with CiTop™ ExPander™ Guidewire in Chronic Coronary Total Occlusion. Gujarat Medical Journal 2010;5(7):117-120.
9. Chag Milan, Gupta Satya, Chandarana Anish, Shah Urmil, Baxi Hemang, Parikh Keyur. Transradial Interventions: Our Experience. Gujarat Medical Journal 2010;5(7):127-130.
10. Nanjundappa Arvind, Siddiqui Yaha, Thompson Stephanie, Parikh Keyur. Blood transfusion: Benefit or Harm? Allogenic Blood Transfusion related Mortality in the Cardiovascular Patient. Gujarat Medical Journal 2010;5(7):131-133.
11. Keyur Parikh. Perspective. Gujarat Medical Journal 2010;5(7):138-140.
12. Stefan James, Andrzej Budaj, Philip Aylward, Kristen K. Buck, Christopher P. Cannon, Jan H. Cornel, Robert A. Harrington, Jay Horrow, Hugo Katus, Matyas Keltai, Basil S. Lewis, Keyur Parikh, Robert

F. Storey, Karolina Szummer, Daniel Wojdyla, Lars Wallentin. Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function: Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation 2010;122:1056-1067.

1. Anjani P Upadhyay, Parloop A Bhatt, Jay J Naik, Keyur H Parikh. Approach to Therapy of Diabetic Patients with Cardiovascular Disorders. Journal of Global Pharma Technology: In Press.
2. Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Bhatt DL, Stone GW, Lincoff MA, Dauerman HL, Gibson CM, White HD, Parikh K, Gruberg L, Herrmann HC, McLaurin BT, Goodman S, Harrington RA, and Mahaffey KW. Pre-Treatment With Thienopyridines Reduces The Amount of Myonecrosis in Acute Coronary Syndrome Patients Invasively Managed: Insights from the CHAMPION trials. Circulation, 2010;122:A14813.
3. Keyur Parikh. Orbital Atherectomy Device: Two Year Follow-up Experience. Presented at ICI Meeting, 2010, Israel.
4. Keyur Parikh. A Three Year’s Clinical Experience Evaluating the Safety of Neovasc Reducer for No Option Patients. Presented at ICI Meeting, 2010, Israel.
5. Satya Gupta, Abhi Patangay, Promadsingh Thakur, Elisa Vireca, Ajay Naik, Hemang Baxi, Urmil Shah, Anish Chandarana, Keyur Parikh. Third Heart Sounds Measured at CRT Device Implant Sites are Correlated to Echocardiographic Filling Parameters in Ambulatory Heart Failure Patient. 2011 HRS Abstract On TRAC HF Study.
6. Satya Gupta, Abhi Patangay, Promadsingh Thakur, Elisa Vireca, Ajay Naik, Hemang Baxi, Urmil Shah, Anish Chandarana, Keyur Parikh. Transient Heart Rate Responses to Transitions in Posture in Ambulatory Heart Failure Patients are Correlated to BNP. Heart Failure Society of America 2011 HFSA Abstract Number – 150398.
7. Rubin L, Parikh K, Pulido T, Jerjes-Sanchez C, Allen R, White RJ, Torbicki A, Xu KF, Yehle D, Laliberte K, Arneson C, Jing ZC. FREEDOM-M: Efficacy and Safety of Oral Treprostinil Diethanolamine as Monotherapy in Patients with Pulmonary Arterial Hypertension. Chest Meeting, 26 Oct 2011.
8. Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Bhatt DL, Stone GW, Lincoff MA, Dauerman HL, Gibson CM, White HD, Parikh K, Gruberg L, Herrmann HC, McLaurin BT, Goodman S, Harrington RA, and Mahaffey KW. Maintenance Therapy with Thienopyridines May Reduce Enzymatic Infarct Size in Patients with Acute Coronary Syndrome Undergoing PCI: Insights from the CHAMPION PCI Trial. Circulation: In Process.
9. Bhavik Shah, Keyur Parikh, Shailaja Mahajan. Baseline characteristics, intervention modalities and utilization of evidence based medications among ACS patients: does presence of diabetes affect the presentation as well as management scenario for ACS? – results from single centric cross-sectional study from India. Poster Presentation at ISPOR 14th Annual European Congress, 7^th November, 2011.
10. Keyur Parikh, Praveen Chandra, Apurva Patel, Milan Chag, Jeff Chambers. Six Month Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions (ORBIT I Trial). J Am Coll Cardiol 2011;58;B172-B173.
11. Keyur Parikh, Roosha Parikh, Apurva Patel, Milan Chag. Two Year Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions – A Single Center Experience. J Am Coll Cardiol 2011;58;B174.
12. Keyur Parikh. Promise of Newer Antiplatelet Agents in PCI. Abstract Book of ICI Meeting, 5^th

December 2011, Israel.

1. Keyur Parikh. Regulatory Aspects in India. Abstract Book of ICI Meeting, 5^th December 2011, Israel.
2. Keyur Parikh, Roosha Parikh, Apurva Patel, Milan Chag. Orbital Atherectomy System in Treating Calcified Coronary Lesion: First in Man Assessment- 3 Year Follow Up. Abstract Book of ICI Meeting (Technology Parade), 5^th December 2011, Israel.
3. Keyur Parikh. Use of Extraction Devices in Acute Myocardial Infarction-Are we there or do we need More Trials? Abstract Book of ICI Meeting, 6^th December 2011, Israel.
4. Keyur Parikh, Parloop Bhatt. Correlation between Insulin Resistance and Altered Thyroid State. Abstract Accepted; CSI, 8-11 December 2011, Mumbai, India
5. Keyur Parikh. Parloop Bhatt, JL Mehta, Abhishek Deshmukh. Correlation between Depression and Cardiovascular Disease. Abstract Accepted; CSI, 8-11 December 2011, Mumbai, India.
6. Keyur Parikh, MD, DM, FACC, FESC, FSCAI, FAPSIC; Praveen Chandra, MD, DM, FACC, FESC, FSCAI, FAPSIC; Nishit Choksi, MD; FACC; P.K. Khanna, MD, FACC; Jeff Chambers, MD, FACC. Safety and Feasibility of Orbital Atherectomy for the Treatment of Calcified Coronary Lesions – the ORBIT I Trial. Accepted: CCI 2012.
7. Edoardo Camenzind, William Wijns, Laura Mauri, Volkhard Kurowski, Keyur Parikh, Runlin Gao, Christoph Bode, John P Greenwood, Eric Boersma, Pascal Vranckx, Eugene McFadden, Patrick W Serruys, William W O’Neil, Brenda Jorissen, Frank Van Leeuwen, Ph Gabriel Steg, for the PROTECT

Steering Committee and Investigators. Protect Trial: Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised multicentre open-label trial. Accepted: CCI 2012.

1. Keyur Parikh: Gender Related Disparity in Cardiovascular Risk Factors and Treatment Options. Abstract Accepted: TCT 2012, Miami Beach Convention Center.
2. Keyur Parikh: Radial Percutaneous Transluminal Angioplasty with Stenting of Celiac Artery and Suprarenal Abdominal Aorta in Ventilated Patient with Takayasu Arteritis and Severe Heart Failure. Edited Live Case-Main Session- Accepted: TCT 2012, Miami Beach Convention Center.
3. Satya Gupta, Keyur Parikh, Parloop Bhatt. A Prospective Study to Relate Gastrointestinal Distress with Depression and Quality of Life in Cardiovascular Disease Patients. Poster presentation at Innovations in Cardiovascular Interventions (ICI) Conference, Tel-Aviv, Israel, Dec 2012.
4. Upendra Kaul, KK Sethi, JJ Dalal, K Parikh, M S Hiremath, AS Mullasari. TRACE: A MulTicenter Retrospective Study to understand Anti-thrombotic treatment patterns and outcomes of Acute Coronary syndrome patients in India. Accepted as an oral presentation in CSI – 2012.z
5. Camenzind, E., Wijns, W., Mauri, L., Kurowski, V., Parikh, K., Gao, R., Bode, C., Greenwood, J.P., Boersma, E., Vranckx, P., McFadden, E., Serruys, P.W., O’neil, W.W., Jorissen, B., Van Leeuwen, F., Steg, P.G. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus- eluting coronary stent implantation: A randomised, multicentre, open-label, controlled trial (PROTECT). The Lancet: Volume 380, issue 9851, year 2012.
6. Keyur Parikh: Three Years Follow Up Data Demonstrate Safe And Effective Treatment Of De Novo Calcified Coronary Lesions By Orbital Atherectomy. Accepted as Poster Presentation at CRT 2013.
7. Sergio Leonardi, MD, MHS, Amanda Stebbins, Meredith Todd, Deepak L. Bhatt, MD, Gregg W. Stone, MD, A. Michael Lincoff, MD, Harold L. Dauerman, MD, C. Michael Gibson, MD, Harvey D. White, DSc, Keyur H. Parikh, MD. “Quantification of Clopidogrel Effect on Enzymatic Infarct Size Related to Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes: Insights from the CHAMPION PCI Trial.” accepted for publication in Coronary Artery Disease
8. Parikh K et al. – The ORBIT I trial evaluated the safety and performance of an orbital atherectomy system (OAS) for the treatment of de novo calcified coronary lesions. The ORBIT I trial suggests that the OAS may offer an effective method to change compliance of calcified coronary lesions to facilitate optimal stent placement in these difficult to treat patients. A larger trial is required to establish safety and overall effectiveness of the OAS in treating calcified coronary lesions. Featured on www.MDLinx.com site.
9. CRT-126 Three Years Follow Up Data Demonstrate Safe And Effective Treatment Of De Novo Calcified Coronary Lesions By Orbital Atherectomy System. Keyur Parikh; Roosha Parikh; Apurva Patel; Milan Chag. Published in JACC: Published in Cardiovascular Interventions CRT 2013 Supplement: Volume 6, Number 2 S.
10. White RJ, Jing ZC, Parikh K, et al: An Open-Label Extension Trial of Oral Treprostinil in Subjects with Pulmonary Arterial Hypertension (TDE-PH-304); ATS Poster Presentation, June 2013.
11. Keyur Parikh, Roosha Parikh, Apurva Patel, Milan Chag: Three Years Follow Up Data Demonstrate Safe And Effective Treatment Of De Novo Calcified Coronary Lesions By Orbital Atherectomy System. Accepted as abstract at CRT 2013, Washington DC.
12. Keyur Parikh,*MD, Praveen Chandra, MD, Nishit Choksi, MD,Puneet Khanna,MD, and Jeffrey Chambers, MD-Safety and Feasibility of Orbital Atherectomy for the Treatment of Calcified Coronary Lesions:The ORBIT I Trial. Catheterization and Cardiovascular Interventions June 2013 Volume 81, Issue 7, 1134-1139.
13. Apurva Patel, Roosha Parikh, Anish Chandarana, Parloop Bhatt, Milan Chag, Satya Gupta, Hemang Baxi, Vineet Sankhla, Mehul Dudhasia, Urmil Shah, Keyur Parikh: Short-term Outcomes In Coronary Artery Disease Patients With Multi-Lesion Disease Implanted With Multiple Bioabsorbable Vascular Scaffolds. (Submitted in American College of Cardiology ACC March -2014)
14. Roosha Parikh, Apurva Patel, Parth Parikh, Keyur Parikh, Dhaval Naik, Niren Bhavsar, Hiren Dholakia, Chintan Mehta, Neil Mehta, Parloop Bhatt, Jawahar Mehta, Dhiren Shah: A Hospital to Home Health Care Initiative for Early Follow-up, Post Discharge Management, Patient Self Care and Activation Following Coronary Artery Bypass Graft Surgery – A First Indian Pilot Study (Submitted in American College of Cardiology ACC March -2014)
15. Apurva Patel, Roosha Parikh, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Chintan Mehta, Neil Mehta, Jawahar Mehta, Parloop Bhatt, Keyur Parikh: A Hospital to Home Visit Model to Ensure Medical Compliance and Reduce Complications Following Percutaneous Coronary Intervention: A Novel Global Concept. Accepted as a presentation at the SCAI 2014
16. Niren Bhavsar, Roosha Parikh, Apurva Patel, Parth Parikh, Satya Gupta, Dhaval Naik, Chintan Mehta, Parloop Bhatt, Keyur Parikh, Dhiren Shah: Comparative Safety and Efficacy Evaluation of Ivabradine, Metoprolol and its Combination in Management of Inappropriate Sinus Tachycardia in Coronary Artery Bypass Graft patients. (Submitted in American College of Cardiology ACC March – 2014)
17. Roosha Parikh, Apurva Patel, Shmuel Banai, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Ajay Naik, Satya Gupta, Vineet Sankhla, Parloop Bhatt, Keyur Parikh: A Possible Alternative Percutaneous Treatment for Patients with Disabling No-Option Angina: “Neovasc” Coronary Sinus Reducer Assessment – 8 Year Follow Up. Accepted as a poster presentation at the SCAI 2014
18. Apurva Patel, Roosha Parikh, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Parloop Bhatt, Keyur Parikh: Orbital Atherectomy System in Treating Calcified Coronary Lesions: First in Man Assessment- 5 Year Follow Up. Accepted as a poster presentation at the SCAI 2014.
19. Roosha Parikh, Apurva Patel, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Piyush Thakar, Jawahar Mehta, Parloop Bhatt, Vineet Sankhla, Keyur Parikh: Increasing Penetration of Drug Eluting Stents in Developing Countries – A Single Center 10 year Study (Submitted in American College of Cardiology ACC March -2014)
20. Parloop Bhatt, Apurva Patel, Roosha Parikh, Parth Parikh, Aditi Patel, Satya Gupta, Jawahar Mehta, Wafia Eteiba, Sharon Mulvagh, Giuseppe Ambrosio, Naranjan Dhalla, James Willerson, Keyur Parikh: International Task Force for Prevention of Cardiovascular Disease: Determining Factors to Assess Primary Prevention Outcomes in Western India (Submitted in American College of Cardiology ACC March -2014)
21. Parloop Bhatt, Parth Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Roosha Parikh, Keyur Parikh: Orbital Atherectomy System in Treating Calcified Coronary Lesions: 3-Year Follow-Up in First Human Use Study (ORBIT I Trial). Accepted as a publication Cardiovascular Revascularization Medicine, Vol. 15, Issue 4.
22. William Wijns, Ph. Gabriel Steg, Laura Mauri, Volkhard Kurowski, Keyur Parikh, Runlin Gao, Christoph Bode, John P. Greenwood, Erik Lipsic, Farqad Alamgir, Tessa Rademaker-Havinga, Eric Boersma, Peter Radke, Frank van Leeuwen, and Edoardo Camenzind for the PROTECT Steering Committee and Investigators- Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4 year results  of the

PROTECT randomized trial. Accepted and Published in European Heart Journal Advance Access published August 8, 2014

1. Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Anish Chandarana, Parloop Bhatt, Milan Chag, Satya Gupta, Hemang Baxi, Vineet Sankhla, Piyush Thakar, Aditi Nanavati, Urmil Shah, Keyur Parikh. Bioresorbable Scaffolds: An Alternative to Newer Generation Drug Eluting Stents in patients with Multi-Lesion Multi vessel Coronary Artery Disease (Submitted in American College of Cardiology ACC March -2015)
2. Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Keyur Parikh. Novel First in man use of first ever sirolimus Drug Coated Balloon in carotid instent restenosis. (Accepted as a Poster Presentation in American College of Cardiology ACC March -2015)
3. Parloop Bhatt, Aditi Patel, Parth Parikh, Jawahar Mehta, Piyush Thakar, Aditi Nanavati, Roosha Parikh, Apurva Patel, Keyur Parikh. Depression and Outcome of Patients with Acute Coronary Syndrome: A 3 Year Follow-up Study. (Accepted as a Poster Presentation in American College of Cardiology ACC March -2015)
4. Parth Parikh, Aditi Patel, Parloop Bhatt, Apurva Patel, Roosha Parikh, Keyur Parikh. A Comparative Study Of Risk Factors And Age of Revascularization In Indian (Asian) Patients With Coronary Artery Disease. (Submitted in American College of Cardiology ACC March -2015)
5. Aditi Patel, Parth Parikh, Roosha Parikh, Apurva Patel, Parloop Bhatt, Aditi Nanavati, Piyush Thakar, Ajay Naik, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Keyur Parikh. Prevalence, Assessment and Clinical Outcome in Cardiovascular Disease: Gender Disparities in Indian Population. (Submitted in American College of Cardiology ACC March -2015)
6. Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Anish Chandarana, parloop bhatt, Milan Chag, Urmil Shah, Hemang Baxi, Satya Gupta, Vineet Sankhla, Keyur Parikh. Drug Coated Balloon: A Safe and innovative application with a new first Sirolimus Drug Coated Balloon (DCB)-Magic TouchTM for complex Coronary Artery Disease with In-stent restenosis, bifurcation disease and small vessel disease. (Submitted in American College of Cardiology ACC March -2015)
7. Parloop Bhatt, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Hemang Baxi, Urmil Shah, Ajay Naik, Satya Gupta, Sankhla Vineet, Dhiren Shah, Aditi Nanavati, Piyush Thakar, Kinjal Shah, Keyur Parikh. Modeling the Treatment Burden of Young Coronary Artery Disease in India. (Submitted in American College of Cardiology ACC March -2015)
8. Keyur Parikh, Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Hemang Baxi, Sirolimus Drug Coated Balloon (DCB): A Novel Approach In Treatment Of Below The Knee Lesions in Critical Limb Ischemia With First Ever Sirolimus Drug Coated Balloons. (Submitted in American College of Cardiology ACC March -2015)
9. Parloop Bhatt, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Jawahar L. Mehta, Keyur Parikh: Unique Aspects of Coronary Artery Disease in Indian Women Abstract Accepted; Cardiovascular Drug & Therapy, 26^th May 2015, by Springer.
10. Keyur Parikh, Hemang Baxi: Response to renal denervation in an Indian population: Six month outcomes in HTN – India (Abstract Accepted: Indian Heart Journal, at the 67^th Annual Conference of Cardiology Society of India (2015)
11. Parloop Bhatt, Kalpesh Prajapati, Ronak Patel, Akshaya Nath, Keyur Parikh, Prevalence of Cardiovascular Disease in India: Hype or Hope Accepted in SCAI 2015
12. Parloop Bhatt, Parth Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Roosha Parikh, Keyur Parikh: Long-term Safety and Performance of the Orbital Atherectomy System for Treating Calcified Coronary    Artery    Lesions:     5-Year     Follow-Up     in     the     ORBIT     I     Trial Cardiovascular Revascularization Medicine. (Accepted as a publication Cardiovascular Revascularization Medicine 2016, S1553-8389 (15) 00091-3
13. Keyur Parikh, Ranjan Shetty, Sameer Dani, Parloop Bhatt, Manish Doshi, Prakash Sojitra. Real- world Safety and Outcome Measures of Novel Sirolimus Coated Balloon Catheter. Accepted in ACC 2016.
14. Poonam Chodvadiya, Keyur Parikh, Ranjan Shetty, Sameer Dani, N. Prathapkumar: Sirolimus Coated Balloon in the Treatment of Acute Coronary Syndrome: Result from the Nanolute Registry Abstract Accepted: TCT 388 Journal of The American College of Cardiology Vol 68. No 18 Suppl 8, 2016
15. Milan Chag, Parloop Bhatt, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Aditi Nanavati, Piyush Thakar, Keyur Parikh. Hospital to Home Visit, an Effective Health Care Initiative to Reduce Complications and Improve Drug Compliance and Adherence: NCDR^® Participation Advantage. Accepted in NCDR 2016.
16. Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Keyur Parikh, Parloop Bhatt. NCDR^® as a Resource to Develop Cardiac Disease Specific Clinical Care Clinics. Accepted in NCDR 2016.
17. Urmil Shah, Milan Chag, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Keyur Parikh, Parloop Bhatt. An Asian Indian Single Centre Radial Access Percutaneous Coronary Intervention Experience: NCDR^® Findings. Accepted in NCDR 2016.
18. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Roosha Parikh, Apurva Patel, Aditi Nanavati, Piyush Thakar, Jawahar Mehta, Keyur Parikh. Depression Adversely Affects Long Term Outcomes in Acute Coronary Syndrome Patients: A Real World Scenario. Accepted in SCAI 2016.
19. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Aditi Patel, Vatsal Chhaya, Anish Chandarana, Hemang Baxi, Urmil Shah, Dhiren Shah, Ajay Naik, Keyur Parikh. Temporal Trends in Young Indian Heart Failure Patients: A Ray of Hope. Accepted in SCAI 2016.
20. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Apurva Patel, Aditi Nanavati, Anish Chandarana, Hemang Baxi, Keyur Parikh. Effect of Mono- therapy versus Combinational Therapy on Exercise Capacity of Pulmonary Arterial Hypertension Patients: Actual Care Data. Accepted in SCAI 2016.
21. Satya Gupta, Parloop Bhatt, Milan Chag, Nairuti Trivedi, Keyur Parikh, Apurva Patel, Roosha Parikh, Parth Parikh, Aditi Patel, Jawahar Mehta, Dhiren Shah. Chest Pain in Acute Coronary Syndrome Patients with Depression after Bypass Surgery. Accepted in SCAI 2016.
22. Satya Gupta, Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Anish Chandarana, Milan Chag, Hemang Baxi, Urmil Shah, Keyur Parikh. Sustained Long Term Safety Outcomes of “NEOVASC” Coronary Sinus Reducer in No-Option Patients of Refractory Angina: 10 Year Follow-up Accepted in SCAI 2016.
23. Parloop Bhatt, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Jawahar Mehta, Keyur Parikh, Unique Aspects of Coronary Artery Diseases in India Women (August 2015, Volume 29, Issue 4, pp 369–376) Accepted: at Cardiovascular Drugs and Therapy
24. Parth Parikh, Apurva Patel, Parloop Bhatt, Milan Chag, Roosha Parikh, Anish Chandarana, Hemang Baxi, Satya Gupta, Vipul Kapoor, Vineet Sankhla, Keyur Parikh, Care Institute Medical Sciences, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: Evaluation of a New Radiation Protection Technology (Cardio-TRAP®) in Transradial Percutaneous Coronary Intervention Procedures Abstract Accepted: at ACC March 2017
25. Parth Parikh, Parloop Bhatt, Vipul Kapoor, Hemang Baxi, Satya Gupta, Tejas Patel, Anish Chandarana, Roosha Parikh, Apurva Patel, Keyur Parikh, Cleveland Clinic, Care Institute of Medical Sciences (CIMS) Optimal P2Y12 Inhibitors for Primary Percutaneous Coronary Intervention Patients in ST Segment Elevation Myocardial Infarction: Actual Care Trends and Outcomes (Accepted at the SCAI 2017 Scientific Sessions in New Orleans, LA May 10 – 13, 2017)
26. Patel B Krunal, Chag C Milan, Gupta B Satya, Bhatt A Parloop, Parikh K Parth, Patel Aditi, Patel K Apurva, Jain N Neil, Parikh H Keyur, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: FIRST IN MAN VASCULAR USE OF AXIOSTAT^®: A NOVEL WHOLE CHITOSAN HAEMOSTATIC DRESSING FOR TRANSRADIAL CORONARY INTERVENTION Accepted: At WEC, Rajasthan, India, October, 2017
27. Parikh K Parth, Patel B Krunal,Chag C Milan, Gupta B Satya, Bhatt A Parloop, Parikh K Parth, Patel Aditi , Patel K Apurva, Jain N Neil, Parikh H Keyur, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: SUPERIORITY OF NEWER ORAL P2Y12 INHIBITORS IN TREATMENT IN CORONARY ARTERY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION AT A HIGH VOLUME NON-US CENTER Abstract Accepted: at WEC, Rajasthan, India, October, 2017
28. Parloop Bhatt, Parth Parikh, Ajay Naik, Milan Chag, Vineet Sankhla, Dhiren Shah, Dhaval Naik, Sophy Patel, Khushbu Thakkar, Neil Jain, Aenasha Chag, Zarna Patel, Piyush Thakar, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India: Impact of Diabetes on Treatment and Outcomes of Patients With Heart Failure: Heart Failure Clinic Analysis (Submitted in American College of Cardiology ACC March -2018)
29. Keyur H. Parikh, Parth Parikh, Parloop Bhatt, Satya Gupta, Hemang Baxi, Urmil Shah, Tejas Patel, Milan Chag, Sameer Dani, Ranjan Shetty, Prathap Kumar, Jagdish Hiremath, Dinesh Shah, Manish Doshi, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland Clinic, India: Prospective Real World Registry for the Use of Sirolimus Coated Balloon in Small Vessel De Novo Lesions (Accepted in American College of Cardiology ACC March -2018)
30. Parloop Bhatt, Parth Parikh, Aditi Nanavati, Zarana Patel, Palak Patel, Piyush Thakar, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India: ST-segment Elevation Myocardial Infarction In Women With Type 2 Diabetes Mellitus(Submitted in American College of Cardiology ACC March -2018)
31. Parloop Bhatt, Parth Parikh, Hemang Baxi, Urmil Shah, Satya Gupta, Tejas Patel, Shreyasharlet John, Aenasha Chag, Palak Patel, Aditi Nanavati, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India: Clinical Research Participant Satisfaction Analysis Outcomes: A Prospective Study in a Developing Nation Cardiology Center (Submitted in American College of Cardiology ACC March -2018)
32. Parloop Bhatt, Parth Parikh, Anish Chandarana, Milan Chag, Vipul Kapoor, Aditi Nanavati, Tejas Patel, Satya Gupta, Hemang Baxi, Urmil Shah, Vineet Sankhla, Neil Jain, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India: Impact of Drug Eluting Stent Price Reduction in India:Selection for Stent Type Placement and Associated Outcomes (Accepted in American College of Cardiology ACC March -2018)
33. Keyur H. Parikh, Parth Parikh, Parloop Bhatt, Aenasha Chag, Hemang Baxi, Milan Chag, Urmil Shah, Satya Gupta, Anish Chandarana, Manish Doshi, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: Real World Clinical Outcomes of Sirolimus Coated Balloon in Coronary Artery Lesions: Results from Single Centre Study(Accepted in American College of Cardiology ACC March -2018)
34. Keyur H. Parikh, Parth Parikh, Deepa Shah, Parloop Bhatt, Piyush Thakar, Ajay Naik, Hemang Baxi, Shmuel Banai, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: Coronary Sinus Reducer^TM Retains Patency and Efficacy at Twelve Years: A Prospective Cardiac CT Angiography Outcomes(Accepted in American College of Cardiology ACC March -2018)
35. Parloop Bhatt, Parth Parikh, Ajay Naik, Milan Chag, Vineet Sankhla, Dhiren Shah, Dhaval Naik, Sophy Patel, Khushbu Thakkar, Neil Jain, Aenasha Chag, Zarna Patel, Piyush Thakar, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India, Impact of Diabetes on Treatment and Outcomes of Patients With Heart Failure: Heart Failure Clinic Analysis Abstract submitted at SCAI 2018
36. Parloop Bhatt, Parth Parikh, Aditi Nanavati, Zarana Patel, Palak Patel, Piyush Thakar, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India ST-segment Elevation Myocardial Infarction In Women With Type 2 Diabetes Mellitus Abstract submitted at SCAI 2018
37. Parloop Bhatt, Parth Parikh, Hemang Baxi, Urmil Shah, Satya Gupta, Tejas Patel, Shreyasharlet John, Aenasha Chag, Palak Patel, Aditi Nanavati, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India Clinical Research Participant Satisfaction Analysis Outcomes: A Prospective Study in a Developing Nation Cardiology Center Abstract submitted at SCAI 2018
38. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh NCDR^® as a Resource Improvement in Hospital Quality Parameters Abstract Accepted at NCDR 2018
39. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh Achieving Highest Benchmarks in Interventional Cardiology: NCDR® Cath PCI a Critical Contributing Factor Abstract Accepted at NCDR 2018
40. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh Reduced Median Fluoro Time: An Outcome of NCDR^® Participation Abstract Accepted at NCDR 2018
41. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh Reduced Percutaneous Coronary Intervention In-hospital Risk Adjusted Rate of Mortality And Bleeding Events via Radial Access: NCDR^® Findings Abstract Accepted at NCDR 2018
42. Keyur H. Parikh, Sameer Dani, Ranjan Shetty, Prathap Kumar, J.S.Hiremath, Dinesh Shah : Sirolimus Coated Balloon For the Treatment of Coronary Artery Stenosis: Long Term Outcome From a Real World Experience (Abstract Accepted in American College of Cardiology ACC March -2018)
43. Keyur H. Parikh, Sameer Dani, Ranjan Shetty, Prathap Kumar, J.S.Hiremath, Dinesh Shah : Treatment of Coronary In-Stent Restenosis With Sirolimus Coated Balloon Catheter: Sub-Analysis Results From Nanolute Study (Abstract Accepted in American College of Cardiology ACC March – 2018)
44. Keyur H. Parikh, Clinical efficacy and safety of Sirolimus coated balloon in a real world single center registry of Indian population (Abstract Accepted at EURO PCR May 2018)
45. Keyur Parikh, PTCA to significant diseased LCX: A challenge (Abstract/Challenging Case Accepted at TCT 2018)
46. Parth Parikh, Parloop Bhatt, Deepa Shah, Piyush Thakar, Ajay Naik, Hemang Baxi, Shmuel Banai, and Keyur Parikh, “First-in-Human Use of Coronary Sinus Reducer in Refractory Angina: 12 Years Anatomical and Clinical Outcomes” (Manuscript submitted at JACC 2018)
47. R. James White, Keyur Parikh, Roblee Allen, Jeremy Feldman, Carlos Jerjez-Sanchez, Lei Pan, Anne Keogh, C. Dario Vizza, Shelley Shapiro, Kathryn Gordon, Meredith Broderick, Sonja Bartolome Long Term Study Of Oral Treprostinil To Treat Pulmonary Arterial Hypertension: Dosing, Tolerability And Pharmacokinetics (Accepted At Pulmonary Circulation 2019).
48. Keyur H. Parikh, Parloop Bhatt, Aditi Nanavati, Piyush Thakar, Tejas Patel, First-In-  Human Use Of Orbital Atherectomy System For Treatment Of Calcified Coronary Lesions: Orbit-I Single Center 10 Years Clinical Outcomes (Submitted In American College Of Cardiology ACC March -2019)
49. Keyur H. Parikh, Parloop Bhatt, Aditi Nanavati, Piyush Thakar, Tejas Patel, Neil Jain, Parth Parikh Blood Cell Count And Its Elements As Risk And Outcome Predictors For Acute Coronary Syndrome: A Finding From 30,216 Subjects In Real World (Submitted In American College Of Cardiology ACC March -2019)
50. Keyur H. Parikh, Parloop Bhatt, Deepa Shah, Aditi Nanavati, Tejas Patel, Neil Jain No  Association Between Hematological Indices And Coronary Calcification In Symptomatic Patients Of Coronary Artery Disease (Submitted In American College Of Cardiology ACC March -2019)
51. Milan Chag, Parloop Bhatt, Piyush Thaker, Keyur Parikh ‘Percutaneous Closure Of Radial Artery Access Site Using Axiostat® Chitosan Haemostatic Dressing’ (Manuscript Submitted At Indian Heart Journal 2019)
52. Keyur Parikh, Parloop Bhatt, Milan Chag, Hemang Baxi, Urmil Shah And Tejas Patel Safety And Efficacy Of Sirolimus Coated Balloon With Nanolute Technology In Real-World Coronary Artery Disease Patients: Angiographic And Clinical Outcomes (Abstract Accepted In EuroPCR 2020)
53. Vipul Kapoor, Parloop Bhatt, Milan Chag, Satya Gupta,Anish Chandarana, Parth Parikh,Apurva Patel, Roosha Parikh, Hemang Baxi, Urmil Shah,Aditi Nanavati Piyush Thakar Keyur Parikh Evaluation Of A New Scatter Radiation Reduction And Ergonomic Support System In A High-Volume, Percutaneous Coronary Diagnosis And Intervention Laboratory (Abstract Accepted in American College of Cardiology ACC March -2020)
54. Amit Patel, Parloop Bhatt, Surabhi Madan, Nitesh Shah, Vipul Thakkar, Bhagyesh Shah, Rashmi Chovatia, Hardik Shah, Minesh Patel, Pradip Dabhi, Aditi Nanavati, Milan Chag, Keyur Parikh. A Comparative COVID 19 Characterizations and    Clinical    Course    Analysis     between     ICU     and     Non ICU Settings. Accepted at medRxiv preprint 10.1101/2020.10.07.20208389 https://doi.org/10.1101/2020.10.07.20208389
55. Amit Patel, Parloop Bhatt, Surabhi Madan, Nitesh Shah, Vipul Thakkar, Bhagyesh Shah, Rashmi Cho vatia, Hardik Shah, Minesh Patel, Pradip Dabhi, Aditi Nanavati, Milan Chag, Keyur Parikh, A Comparative COVID 19 Characterizations and Clinical Course Analysis between ICU and Non ICU Settings doi: https://doi.org/10.1101/2020.10.07.20208389 (Accepted manuscript at medRxiv in Jul-2020)
56. Keyur H. Parikh, Parth Parikh, Krunal Patel, “Rotatripsy”-Combination Of Rotational Atherectomy And Intravascular Lithotripsy For Treatment Of Undilatable Severely Calcified Lesions In Chronic Total Occlusion Of Right Coronary Artery (Accepted as an Interventional Challenging Case in American College of Cardiology, ACC May -2021).
57. Keyur H. Parikh, Parth Parikh, Krunal Patel,A Case Misdiagnosed As A Takayasu Arteritis Successfully Treated With Multi-Vessel Intervention Involving Coronaryarteries, Both Subclavians, And Superficial Femoral Artery(Safari Technique) (Submitted As An Interventional Challenging Case In American College Of Cardiology, ACC May -2021)
58. Keyur H. Parikh, Parloop Bhatt, Vipul Kapoor, Vineet Sankhla, Piyush Thakar, Kaivan Shah, Aenasha Chag, Aarya Naik, Milan Chag, Impact Of Covid-19 Pandemic On Acute St Elevation And Non St Elevation Myocardial Infarctions (Submitted As An Abstract In American College Of Cardiology, ACC May -2021)
59. Keyur H. Parikh, Parloop Bhatt, Vipul Kapoor, Vineet Sankhla, Rina Patel, Kaivan Shah, Aenasha Chag, Aarya Naik, Milan Chag, Cardiology Clinical Trial Management During The Covid-19 Pandemic- Opportunities And Challenges (Submitted As An Abstract In American College Of Cardiology, ACC May -2021)
60. Keyur H. Parikh, Parloop Bhatt, Vipul Kapoor, Vineet Sankhla, Jyoti Bhatia, Aditi Nanavati, Kaivan Shah, Aenasha Chag, Aarya Naik, Milan Chag, Incidence, Association And Outcomes Of Cardiovascular Complications In Covid 19 Hospitalized Patients (Submitted As An Abstract In American College Of Cardiology, ACC May -2021)
61. Keyur H. Parikh, Parloop Bhatt, Vipul Kapoor, Vineet Sankhla, Aditi Nanavati, Kaivan Shah, Aenasha Chag, Aarya Naik, Milan Chag, Impact Of Cardiovascular Disease On Discharge And One Month Follow Up Outcomes Of Covid 19 Patients (Submitted As An Abstract In American College Of Cardiology, ACC May -2021)
62. Keyur H. Parikh, Dhiren Shah, Dhaval Naik, Amit Chandan, Kishore Gupta, Shaunak Shah, Niren Bhavsar, Hiren Dholakia, Chintan Sheth, Parloop Bhatt, Piyush Thakar, Kaivan Shah, Aenasha Chag, Aarya Naik, Assessment And Outcomes 0f Covid 19 Infection Following Cardiac Surgery – A Single Center Experience (Submitted As An Abstract In American College Of Cardiology, ACC May -2021)
63. Keyur Parikh, Vivian K Lee, Taewoo Lee, Amrit Ghosh, Tanmoy Saha, Manish V Bais, Kala Kumar Bharani, Milan Chag, Parloop Bhatt, Bumseok Namgung, Geethapriya Venkataramanan, Animesh Agrawal, Kiran Sonaje, Lee Mavely, Shiladitya Sengupta, Raghunath Anant Mashelkar, Hae Lin Jang, An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy
64. Keyur Parikh, Ahmed Elkoumy, John Jose, Christian J Terkelsen, Henrik Nissen, Sengottuvelu Gunasekaran, Mahmoud Abdelshafy, Ashok Seth, Hesham Elzomor, Sreenivas Kumar, Francesco Bedogni, Alfonso Ielasi, Santosh K Dora, Sharad Chandra, Daniel Unic, William Wijns, Andreas Baumbach, Darren Mylotte, Patrick Serruys, Osama Soliman, Safety and Efficacy of Myval Implantation in Patients with Severe Bicuspid Aortic Valve Stenosis-A Multicenter Real-World Experience
65. Keyur Parikh, Vivian K Lee, Taewoo Lee, Amrit Ghosh, Tanmoy Saha , Manish V Bais , Kala Kumar Bharani , Milan Chag, Parloop Bhatt, Bumseok Namgung, Geethapriya Venkataramanan, Animesh Agrawal, Kiran Sonaje, Leo Mavely, Shiladitya Sengupta, Raghunath Anant Mashelkar, Hae Lin Jang, An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy
66. Keyur Parikh, Praveen Chandra, Selvamani Sethuraman, Sanjeeb Roy, Arun Mohanty, Bahuleyan Charantharalyil Gopalan, Prasant Kumar Sahoo, Sridhar Kasturi, Vijay Trambaklal Shah, Viveka Kumar, Brian Pinto, Pratap Chandra Rath, Vijayachandra Reddy Yerramareddy, Deepak Davidson, Girish B Navasundi, Vijayakumar Subban, Nandhini Livingston, Deva Preethi Rajaraman, Manish Narang, Nick E J West, Ajit Mullasari, Effectiveness and safety of optical coherence tomography-guided PCI in Indian patients with complex lesions: A multicenter, prospective registry
67. Keyur Parikh, Ahmed Elkoumy, John Jose, Christian Juhl Terkelsen, Henrik Nissen, Sengottuvelu Gunasekaran, Mahmoud Abdelshafy, Ashok Seth, Hesham Elzomor, Sreenivas Kumar, Francesco Bedogni, Alfonso Ielasi, Shahram Arsang-Jang, Santosh Kumar Dora, Sharad Chandra, Daniel Unic, Andreas Baumbach, Patrick Serruys, Osama Soliman, One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis-A Multicentre Real-World Experience
68. 209.Keyur Parikh, Tom Devasia, Rajendra Kumar Premchand, Santosh K. Sinha, Atul Rewatkar, and Jaspal Arneja,, Comparing Obtura Vascular Closure Device to Manual Compression for Achieving Hemostasis After Percutaneous Transfemoral Procedures: A Randomized Study

ADDENDUM

CITATIONS

Citation indices up to March 2017

• Citations

All – 2020, Since 2013 – 1388

• h-index

All – 15, Since 2013 – 14

• i10-index

All – 24, Since 2013 – 17

1. Reversal of slow or no-reflow during percutaneous tranluminal coronary angioplasty using boluses of intracoronary adenosine and sodium nitroprusside in combination; KH Parikh, MC Chag, UG Shah, HA Baxi, AH Chandarana, AM Naik, KJ Shah, RK Goyal. Journal of the American College of Cardiology 41 (6s1), 39-40. Year 2003.
2. Improvement in MACE by sequential administration of boluses or intracoronary adenosine and sodium nitroprusside during percutaneous coronary interventions; K Parikh, HD Shah, M Chag, U Shah, H Baxi, A Chandarana, A Naik, RK Goyal. EUROPEAN HEART JOURNAL 25, 518-519. Year 2004.
3. Bosentan in primary pulmonary hypertension; KJ Shah, KH Parikh, RK Goyal. Indian journal of pharmacology 36 (2), 108. Year 2004.
4. A study of stepwise constants and stepwise real absorptivity of cobalt (II) complexes; S Sharma, KH Parikh, JN Patel, MC Shah, JJ Vora, JD Joshi. ULTRA SCIENTIST OF PHYSICAL SCIENCES 16, 45-50. Year 2004.
5. Homocysteine and coronary artery disease; KJ Shah, MC Chag, KH Parikh, RK Goyal Indian journal of pharmaceutical sciences 66 (5), 595-601. Year 2004.
6. Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease; U Elkayam, K Parikh, B Torkan, L Weber, JL Cohen, SH Rahimtoola. The American journal of cardiology 55 (11), 1393-1395. Year 1985.
7. Effect of folate treatment on homocysteinemia in cardiac patients: A prospective study; KN Mehta, MC Chag, KH Parikh, UG Shah, HA Baxi, AH Chandarana, AM Naik, RK Goyal. Indian journal of pharmacology 37 (1), 13. Year 2005.
8. Effect of metoprolol CR/XL on pulmonary artery pressure in patients with heart failure measured using first in human implantable device responding to ultrasonic signal; KH Parikh, HD Shah, MC Chag,     UG     Shah,     HA     Baxi,     AH     Chandarana,     AM      Naik,      JN      … JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 310A-310A. Year 2006.
9. Assessment of use of Glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions; KH Parikh, MC Chag, UG Shah, AH Chandarana, HA Baxi, AM Naik, RK Goyal. Journal of Molecular and Cellular Cardiology 41 (4), 746. Year 2006.
10. First in man: MultiSlice CT angiography visualization of an innovative first-in-man coronary sinus reducer stent in patients with refractory angina; KH Parikh, HA Shah, AH Chandarana, AM Naik, MC Chag, UG Shah, HA Baxi, JN … AMERICAN JOURNAL OF CARDIOLOGY 98 (8 A), 90M- 91M. Year 2006.
11. First in man: Direct comparison of conventional coronary sinus angiography and CT angiography for visualization and sizing of coronary sinus; KH Parikh, AM Naik, HA Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, JN … AMERICAN JOURNAL OF CARDIOLOGY 98 (8 A), 90M- 90M. Year 2006.
12. First in man non-invasive monitoring of pulmonary artery pressure from an implantable device using acoustic telemetry: a one year follow-up data; K Parikh, AM Naik, HA Shah, HA Baxi, MC Chag, UG Shah, AH Chandarana, Y Rozenman. EUROPEAN HEART JOURNAL 27, 202-202. Year 2006.
13. First in Man study: effect of metoprolol CR/XL on diurnal variation in pulmonary artery pressure assessed non-invasively using an innovative implantable device responding to ultrasonic signals; H Shah, RK Goyal, AM Naik, HA Baxi, MC Chag, A Hjalmarson, Y Rozenman, KH Parikh. EUROPEAN HEART JOURNAL 27, 344-344. Year 2006.
14. First in man: effect of metoprolol CR/XL on exercise capacity and subsequent variation in Pulmonary Artery Pressure in Heart Failure patients using an innovative implant involving acoustic telemetry; K Parikh, HA Shah, AM Naik, HA Baxi, MC Chag, AH Chandarana, A Hjalmarson, Y

… EUROPEAN HEART JOURNAL 27, 949-949. Year 2006.

1. First-In-Man: comparison of impressure device measuring pulmonary artery pressure non- invasively with conventional contrast echocardiography in congestive heart failure; MC Chag, HA Shah, AM Naik, HA Baxi, UG Shah, AH Chandarana, Y Rozenman, KH … EUROPEAN HEART JOURNAL 27, 202-202. Year 2006.
2. First in man: measurement of diurnal variation in pulmonary artery systolic and diastolic pressure in heart failure patients using an innovative implantable device responding to ultrasonic signals; K Parikh, HA Shah, AM Naik, HA Baxi, MC Chag, AH Chandarana, A Hjalmarson, Y … EUROPEAN HEART JOURNAL 27, 485-485. Year 2006.
3. First in Man: non invasive measurement of variation in Pulmonary artery pressure following exercise in heart failure patients using an innovative implantable device involving acoustic telemetry. K Parikh, HA Shah, AM Naik, HA Baxi, MC Chag, UG Shah, A Hjalmarson, Y Rozenman. EUROPEAN HEART JOURNAL 27, 949-949. Year 2006.
4. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no reflow during angioplasty: A clinical scenario of experimental preconditioning; HD Shah, RK Goyal, KH Parikh. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 381A-382A. Year 2006.
5. First in human implanted device in pulmonary artery using acoustic telemetry based on noninvasive ultrasound activation and communication; KH Parikh, HD Shah, MC Chag, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN … JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 50B-50B. Year 2006.
6. First in man: Coronary sinus narrowing with a reducer stent-A possible alternative percutaneous treatment for patients with refractory angina; S Banai, G Keren, H Sievert, A Seth, S Ben Muvhar, AM Naik, A Medina, P … JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 17B-17B. Year 2006.
7. Effect of metoprolol CR/XL on diurnal variation in pulmonary artery pressure measured noninvasively using first in human implant responding to ultrasonic signals; KH Parikh, HD Shah, MC    Chag,    UG    Shah,    HA    Baxi,    AH    Chandarana,    AM     Naik,     JN     … JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 370A-370A. Year 2006.
8. A vigilance study of distal protection device used during percutaneous coronary interventions; K Shah,   K   Parikh,   M   Chag,   U   Shah,   A   Chandarana,   H   Baxi,   A   Naik,   RK   Goyal The International Journal of Risk and Safety in Medicine 18 (4), 205-212. Year 2006.
9. Coronary Sinus Reducer Stent for the Treatment of Chronic Refractory Angina PectorisA Prospective, Open-Label, Multicenter, Safety Feasibility First-in-Man Study; S Banai, SB Muvhar, KH Parikh, A Medina, H Sievert, A Seth, J Tsehori, Y Paz … Journal of the American College of Cardiology 49 (17), 1783-1789. Year 2007.
10. First-in-man: effect of Metoprolol CR/XL uptitration on pulmonary artery pressure and its variation in chronic heart failure monitored non-invasively by an implanted device using ultrasonic signals; HA Shah, AM Naik, HA Baxi, MC Chag, UG Shah, AH Chandarana, RK Goyal, Y … EUROPEAN HEART JOURNAL 28, 521-521. Year 2007.
11. Need for concurrent renal angiography during coronary angiography in patients with severe coronary artery disease and hypertension: Analysis of 500 consecutive. A Chandarana, M Chug, K Parikh, H Baxi, U Shah, A Shah, J Shah, M Tanna, H … AMERICAN JOURNAL OF CARDIOLOGY 99 (8), 88F-88F. Year 2007.
12. Wireless acoustic communication with a miniature pressure sensor in the pulmonary artery for disease surveillance and therapy of patients with congestive heart failure; Y Rozenman, RS Schwartz, H Shah, KH Parikh. Journal of the American College of Cardiology 49 (7), 784-789. Year 2007.
13. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no- reflow during angioplasty: a clinical scenario of ischemic preconditioning This paper is one of a selection of papers published in this Special Issue, entitled The Cellular and Molecular Basis of Cardiovascular Dysfunction, Dhalla 70th Birthday Tribute; KH Parikh, MC Chag, KJ Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN … Canadian journal of physiology and pharmacology 85 (3-4), 476-482. Year 2007.
14. Effect of pioglitazone and its combination with statins in coronary artery disease patients with hyperinsulinemia; A Mehta, U Shah, K Parikh, M Chag, H Baxi, A Chandarana, A Naik, A Naik, K … Canadian journal of physiology and pharmacology 85 (6), 628-633. Year 2007.
15. EXPORT study; B Chevalier, K Parikh, M Gilard, I Lang. Year 2007.
16. Beneficial effects of the addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions; HD Shah, KH Parikh, MC Chag, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN … Experimental & Clinical Cardiology 12 (2), 91. Year 2007.
17. Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter; B CHEVALIER, M GILARD, I LANG, P COMMEAU, J ROOSEN, M HANSSEN, T LEFEVRE, D … EuroIntervention 4 (2), 222-228. Year 2008.
18. Efficacy of PercuSurge in acute myocardial infarction patients undergoing revascularization with a special emphasis on procedural time; KH Parikh, HA Shah, MC Chag, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN … Indian heart journal 60 (2), 101. Year 2008.
19. Current trend of utilization of evidence based medications among acs patients: A population based cross-sectional     study;     S     Pareek,     R      Balaraman,      B      Shah,      K      Parikh INDIAN JOURNAL OF PHARMACOLOGY 40, 65-65. Year 2008.
20. Ovalum CiTop™ Expander™: a novel guidewire for crossing coronary chronic total occlusions―first-in-man (FIM) experience; KH Parikh, AR Shah, MC Chag, A Segev. EuroIntervention 5 (2), 206-211. Year 2009.
21. Long Term Safety, Angina Relief and Improvement in Quality of Life in Patients with Refractory Angina Treated with the Neovasc Coronary Sinus Reducer; KH Parikh, M Chag, U Shah, H Baxi, A Chanadarana, A Naik, S Gupta, S Banai. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 53 (10), A18-A18. Year 2009.
22. Two-Year Extended Follow-up in Patients Receiving a Zotarolimus-eluting Stent in the E-Five Registry;  MT  Rothman,  IT  Meredith,  K  Parikh,  P  Sick,  F  Feres,  C  Lotan JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 53 (10), A45-A45. Year 2009.
23. First In Man Assessment of Orbital Atherectomy System in Treating De Novo Calcified Coronary Lesions (ORBIT I). KH Parikh, A Seth, H Baxi, A Chandarana, S Gupta, U Shah, M Chag, S Nair, P … JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 53 (10), A20-A20. Year 2009.
24. Research Article Diabetes and Management of Lipid Level Following PCI in Acute Coronary Syndrome Patients; JP Patel, KH Parikh, JC Patel, HD Karen, IS Anand, JS Shah. International Journal of Pharmaceutical Research 1 (4). Year 2009.
25. Clinical Research Article Keyur H. Parikh et al; KH Parikh, A Hetal, C Milan, G Urmil, A Hemang, H Anish, M Ajay, H Ake, K … Indian Heart J 61, 34-39. Year 2009.
26. Platelet inhibition with cangrelor in patients undergoing PCI; RA Harrington, GW Stone, S McNulty, HD White, AM Lincoff, CM Gibson, CV …New England Journal of Medicine 361 (24), 2318-2329. Year 2009
27. Rationale and design of the Patient Related Out comes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation; E Camenzind, W Wijns, L Mauri, E Boersma, K Parikh, V Kurowski, R Gao, C … American heart journal 158 (6), 902-909. e5. Year 2009.
28. Effect of Metoprolol CR/XL on pulmonary artery pressure in chronic heart failure patients assessed by an implanted ultrasonic device with special emphasis on diurnal variation and exercise capacity; KH Parikh, A Hetal, C Milan, G Urmil, A Hemang, C Anish, M Ajay, H Ake, K … Indian heart journal 61 (1), 34. Year 2009.
29. Ovalum CiTop™ Expander™: a novel guidewire for crossing coronary chronic total occlusions―first-in-man (FIM) experience; KH Parikh, AR Shah, MC Chag, A Segev. EuroIntervention 5 (2), 206-211. Year 2009.
30. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function results from the Platelet Inhibition and Patient Outcomes (PLATO) Trial; S James, A Budaj, P Aylward, KK Buck, CP Cannon, JH Cornel, RA Harrington, J …Circulation 122 (11), 1056-1067. Year 2010
31. Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial; J Hiremath, S Thanikachalam, K Parikh, S Shanmugasundaram, S Bangera, L …The Journal of Heart and Lung Transplantation 29 (2), 137-149. Year 2010
32. LONG-TERM FOLLOW-UP TO EVALUATE THE SAFETY OF THE NEOVASC REDUCER A DEVICE-BASED THERAPY FOR CHRONIC REFRACTORY ANGINA; S Banai, M Schwartz, H Sievert, A Seth, G Keren, KH Parikh. Journal of the American College of Cardiology 55 (10s1), A98. E927-A98. E927. Year 2010.
33. A quarter century & change of directions: femoral to   radial   approach?;   KH   Parikh Indian heart journal 62 (3), 191. Year 2010.
34. Extended follow‐up safety and effectiveness of the Endeavor zotarolimus‐eluting stent in real‐ world clinical practice: Two‐year follow‐up from the E‐Five Registry; I Meredith, M Rothman, A Erglis, K Parikh, C Lotan. Catheterization and Cardiovascular Interventions 77 (7), 993-1000. Year 2011.
35. PCV133 Baseline Characteristics, Intervention Modalities and Utilization of Evidence Based Medications Among ACS Patients: Does Presence of Diabetes Affect the Presentation as Well as Management Scenario for ACS?–Results from Single Centric Cross-Sectional Study from India; B Shah, S Mahajan, B Patel, K Parikh Value in Health 14 (7), A388. Year 2011.
36. Six Month Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions (ORBIT I Trial); K Parikh, P Chandra, A Patel, M Chag, J Chambers. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 58 (20), B172-B173. Year 2011.
37. Two Year Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions-A Single Center Experience; K Parikh, R Parikh, A Patel, M Chag. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 58 (20), B174-B174. Year 2011.
38. Cathodic protection of tin-Coated steel in monochloroacetic acid (0.5 mol dm (-3)) in presence of chromates       and       dichromates;       S       Sharma,       KH       Parikh,        M        Neog Journal of the Indian Chemical Society 88 (4), 603-606. Year 2011.
39. FREEDOM-M: efficacy and safety of oral treprostinil diethanolamine as monotherapy in patients with pulmonary arterial hypertension; L Rubin, K Parikh, T Pulido, C Jerjes-Sanchez, R Allen, J White, A Torbicki … CHEST Journal 140 (4_MeetingAbstracts), 1044A-1044A. Year 2011.
40. Pyogenic Granuloma: A report of three cases; K Parikh, P Shah, M Shah. J Dent Sci 2, 53-5. Year 2011.
41. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial; E Camenzind, W Wijns, L Mauri, V Kurowski, K Parikh, R Gao, C Bode, JP … The Lancet. Year 2012
42. Asymmetrical    sine    squared    profiled    corrugated    horn    offers    enhanced    bandwidth KB Parikh, SB Sharma, JV Dave. Emerging Technology Trends in Electronics, Communication and Networking … Year 2012.
43. TCT-364 Gender Related Disparity in Cardiovascular Risk Factors and Treatment Options; P Bhatt, J Naik, R Parikh, P Parikh, J Mehta, K Parikh. Journal of the American College of Cardiology 60 (17_S). Year 2012.
44. A Case Report of Papillon-Lefevre Syndrome; PP Shah, MJ Shah, KK Parikh, FF Khan Journal of Pierre Fauchard Academy 26 (2), 64-68. Year 2012.
45. Assessment of antihypertensive drug use among hypertensive patients presented with acute coronary syndrome; B Shah, B Patel, K Parikh PHARMACOTHERAPY 32 (5), E113-E113. Year 2012.
46. GENDER RELATED DISPARITY IN CARDIOVASCULAR RISK FACTORS AND TREATMENT OPTIONS: AN INDIAN SCENARIO; PA Bhatt, J Naik, P Parikh, K Parikh, JL Mehta. Journal of the American College of Cardiology 59 (13s1), E1459-E1459. Year 2012.
47. For the PROTECT Steering Committee and Investigators. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial; E Camenzind, W Wijns, L Mauri, V Kurowski, K Parikh, R Gao. Lancet 380, 1396-1405. Year 2012.
48. Gabapentin: a suppressant for refractory chronic cough; KF Chung. The Lancet. Year 2012.
49. Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial HypertensionClinical Perspective A Randomized, Controlled Trial; ZC Jing, K Parikh, T Pulido, C Jerjes-Sanchez, RJ White, R Allen, A Torbicki … Circulation 127 (5), 624-633. Year 2013.
50. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF); JJV McMurray, IS Anand, R Diaz, AP Maggioni, C O’Connor, MA Pfeffer, SD … European journal of heart failure 15 (3), 334-341. Year 2013.
51. Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions; K Parikh, P Chandra, N Choksi, P Khanna, J Chambers Catheterization and Cardiovascular Interventions. Year 2013.
52. Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial; S Leonardi, A Stebbins, RD Lopes, Y Lokhnygina, M Todd, DL Bhatt, GW Stone … Coronary artery disease 24 (4), 321-327. Year 2013.
53. A PROSPECTIVE STUDY TO EVALUATE CORRELATION BETWEEN CORONARY HEART DISEASE AND DEPRESSION AND ITS INFLUENCE ON QUALITY OF LIFE AND CLINICAL OUTCOMES; J Mehta, PA Bhatt, B Vaghela, K Parikh. Journal of the American College of Cardiology 61 (10_S). Year 2013.
54. CRT-126 Three Years Follow Up Data Demonstrate Safe And Effective Treatment Of De Novo Calcified Coronary Lesions By Orbital Atherectomy System; K Parikh, R Parikh, A Patel, M Chag. JACC: Cardiovascular Interventions 6 (2_S), S41-S41. Year 2013
55. Published Ahead-of-Print-Last Updated: March 30, 2013; J Kaufmann, E Wellnhofer, K Kappert, D Urban, H Meyborg, T Hauptmann, A …
56. Investigation on Profile Corrugated Horn to yield Low Cross-polarization over Wide Bandwidth; KB Parikh, SB Sharma, JV Dave.
57. B104 JACC Vol 60/17/Suppl B| October 22–26, 2012| TCT Abstracts/POSTER/Gender, Age, and Other Demographic Considerations; P Bhatt, J Naik, R Parikh, P Parikh, J Mehta, K Parikh.
58. ESTIMATION OF CLINICAL PHARMACOKINETIC INTERACTION BETWEEN ATORVASTATIN AND CLOPIDOGREL IN ATHEROSCLEROTIC HEART DISEASE PATIENTS; MD Patel, JS Shah, KH Parikh, PA Bhatt.
59. Experimental & Clinical; RK Goyal, K Parikh.